{"title":"All Peptides","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eWhen it comes to sourcing peptides in Canada, quality, purity, and transparency are non-negotiable. \u003cstrong\u003eUncut Peptides\u003c\/strong\u003e is Canada's premier destination for pharmaceutical-grade research compounds, proudly serving researchers and scientists from coast to coast. Every product in our catalog is third-party tested and backed by a Certificate of Analysis (COA), so you always know exactly what you're getting. Whether you're just starting your research journey or are a seasoned professional, \u003cstrong\u003ewe are the Canadian peptides supplier you can trust for consistent, high-purity compounds — every single time.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2 class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\n\u003cmeta charset=\"utf-8\"\u003eResearch Peptides Built for Serious Science\u003c\/h2\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eOur catalog of research peptides is curated specifically for investigational and laboratory use, synthesized to the highest available purity thresholds, tested for accurate concentration, and stored under optimal conditions prior to shipping. We understand that the integrity of your research depends entirely on the integrity of your compounds — which is why we never cut corners, and we never cut our peptides.\u003c\/p\u003e\n\u003ch2 class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003e\u003cmeta charset=\"utf-8\"\u003eBPC-157\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eBPC-157 \u003c\/strong\u003e(Body Protective Compound-157) is one of the most widely studied peptides in the research community, with a growing body of literature exploring its role in tissue repair, gut health pathways, and musculoskeletal function at the molecular level. Each batch of our \u003cstrong\u003eBPC-157\u003c\/strong\u003e is independently verified for purity and potency, giving Canadian researchers a reliable compound they can build their work around.\u003c\/p\u003e\n\u003ch2 class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\n\u003cmeta charset=\"utf-8\"\u003eRetatrutide\u003c\/h2\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eFor those working at the cutting edge of metabolic research, \u003cstrong\u003eRetatrutide\u003c\/strong\u003e is one of the most exciting next-generation peptides currently under investigation. As a triple-receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously, it represents a true frontier in peptide science. \u003cstrong\u003eUncut Peptides\u003c\/strong\u003e makes it accessible to Canadian researchers with full third-party verification on every batch.\u003c\/p\u003e\n\u003ch2 class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\n\u003cmeta charset=\"utf-8\"\u003eWhy Choose Uncut Peptides?\u003c\/h2\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAt \u003cstrong\u003eUncut Peptides\u003c\/strong\u003e, we hold every compound in our catalog to the same uncompromising standard — rigorous purity testing, transparent COAs, and fast domestic shipping with no cross-border delays. When your research demands the best, we deliver.\u003c\/p\u003e","products":[{"product_id":"buy-retatrutide-canada","title":"GLP-3 (Retatrutide)","description":"\u003ch2\u003e\u003cb\u003eBuy Retatrutide in Canada — Triple-Agonist Research Peptide\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy Retatrutide in Canada as a research-grade triple receptor agonist for metabolic, glycemic, and adiposity research designs. Retatrutide (LY3437943) is an investigational triple GLP-1, GIP, and glucagon receptor agonist developed by Eli Lilly, with Phase 2 clinical data published in 2023 showing dose-dependent body weight reductions and HbA1c improvements. The compound combines balanced agonist activity across all three target receptors with structural modifications — Aib substitutions and C20 fatty diacid acylation — that extend half-life through albumin binding. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e Available on batch-specific COA\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 2381089-83-2\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes Retatrutide a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is the only compound in advanced clinical investigation that simultaneously activates the GLP-1, GIP, and glucagon receptors. Earlier incretin peptides target one or two; the addition of glucagon-receptor agonism reintroduces a hepatic and energy-expenditure dimension that mono- and dual-agonists cannot address.\u003c\/p\u003e\n\u003cp\u003eDeveloped at Eli Lilly and disclosed in 2022 under the code LY3437943, retatrutide carries Aib substitutions for DPP-4 resistance and a C20 fatty diacid for albumin binding and extended circulation. Phase 2 trial data published in 2023 in major peer-reviewed medical journals reported dose-dependent changes in body weight and HbA1c, making it a reference tool compound for researchers comparing the contributions of each receptor pathway.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eGlycemic Regulation —\u003c\/b\u003e Phase 2 trial data published in 2023 reported dose-dependent reductions in HbA1c in study populations with type 2 diabetes, supporting investigation into the contribution of triple-receptor activation to glucose handling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAdiposity \u0026amp; Body Composition —\u003c\/b\u003e Animal and clinical trial datasets describe substantial reductions in fat mass over 24- and 48-week protocols, with investigators attributing the magnitude to combined incretin and glucagon-receptor effects on intake and expenditure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eHepatic Lipid Metabolism —\u003c\/b\u003e Researchers studying NAFLD and MASH models have examined retatrutide's effect on hepatic triglyceride content, where glucagon-receptor agonism is hypothesized to drive intrahepatic lipid mobilization beyond what GLP-1 alone produces.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eEnergy Expenditure —\u003c\/b\u003e Preclinical work in rodent models has reported elevations in resting energy expenditure attributed to the glucagon receptor component, distinguishing retatrutide from GLP-1 monotherapy in mechanistic dissection studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCardiometabolic Markers —\u003c\/b\u003e Secondary endpoints in published trials have included blood pressure, lipid panel, and inflammatory markers, giving researchers additional data points for modeling broader cardiometabolic effects of triple agonism.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with retatrutide often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-tesamorelin-canada\" title=\"View Tesamorelin Product Page\"\u003eTesamorelin\u003c\/a\u003e\u003c\/b\u003e — GH-axis analog studied in visceral adiposity and lipid metabolism research; useful mechanistic contrast to incretin-driven fat mass effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-mots-c-canada\" title=\"View MOTS-c Product Page\"\u003eMOTS-c\u003c\/a\u003e\u003c\/b\u003e — Mitochondria-derived peptide investigated for insulin sensitivity and exercise-mimetic activity; complements retatrutide's receptor-level metabolic effects with a cellular-energetics angle.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/nad-plus\" title=\"View NAD+ Product Page\"\u003eNAD+\u003c\/a\u003e\u003c\/b\u003e — Mitochondrial cofactor studied alongside metabolic peptides in cardiometabolic and longevity research designs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\n\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003cb\u003e\u003c\/b\u003e\n\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eHow is retatrutide different from tirzepatide or semaglutide?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eSemaglutide is a single GLP-1 receptor agonist. Tirzepatide is a dual GLP-1\/GIP agonist. Retatrutide adds a third arm — glucagon receptor agonism — which preclinical and Phase 2 data suggest contributes additional hepatic lipid mobilization and energy expenditure effects not observed with mono- or dual-agonist compounds.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for retatrutide?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePhase 2 trials in obesity and type 2 diabetes have been completed and published in major peer-reviewed medical journals, including data on body weight, glycemic markers, and tolerability. Phase 3 development is ongoing under Eli Lilly's TRIUMPH program. The preclinical literature spans metabolic, hepatic, and energy-expenditure endpoints in rodent and non-human primate models.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs retatrutide naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. Retatrutide is a synthetic 39-amino-acid peptide engineered with non-natural Aib substitutions for protease resistance and a C20 fatty diacid acylation for extended circulation. It does not exist in nature; its sequence is designed to engage GLP-1, GIP, and glucagon receptors simultaneously.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745388290185,"sku":null,"price":89.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg","offer_id":45745388322953,"sku":null,"price":489.99,"currency_code":"CAD","in_stock":true},{"title":"10 x 10mg (one box)","offer_id":45745388355721,"sku":null,"price":739.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/retatrutide-ly3437943-10mg-research-peptide_standardized.png?v=1778371040"},{"product_id":"buy-bpc-157","title":"BPC-157","description":"\u003ch2\u003e\u003cb\u003eBuy BPC-157 — Gastric-Derived Pentadecapeptide\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eBuy BPC-157 from Emerald Peptides as a research-grade pentadecapeptide for tissue repair, cytoprotection, and gastrointestinal research designs. BPC-157 is a synthetic 15-amino-acid peptide derived from a partial sequence of body protective compound (BPC), originally isolated from human gastric juice. With more than 100 published animal studies covering gastrointestinal injury, musculoskeletal repair, vascular research, and neural protection models, BPC-157 has one of the broadest preclinical evidence bases in the recovery research peptide category. Each vial ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e [CONFIRM — common SKU sizes: 5 mg \/ 10 mg]\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₆₂H₉₈N₁₆O₂₂ \/ 1419.55 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 137525-51-0\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes BPC-157 a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eBPC-157 was characterized by Croatian researchers in the early 1990s as a stable fragment of body protective compound, a larger protein found in gastric juice. What set it apart immediately was its stability in acidic gastric environments and its activity without a carrier protein — properties that made it accessible for a wide range of preclinical models.\u003c\/p\u003e\n\u003cp\u003eThe peptide's broad-tissue activity is unusual. Published animal studies report effects on smooth muscle, tendon, ligament, bone, gut mucosa, and vascular endothelium, with mechanistic work pointing to nitric-oxide pathway modulation and pro-angiogenic VEGFR2 signaling. This combination makes BPC-157 a frequent reference compound in repair and cytoprotection research, including studies modeling NSAID-induced gastric injury where conventional models have struggled to find responsive tools.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eGastrointestinal Cytoprotection —\u003c\/b\u003e Animal studies report protective effects against NSAID-induced and stress-induced gastric lesions, with researchers attributing the activity to nitric oxide pathway modulation and mucosal repair signaling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eTendon \u0026amp; Ligament Repair —\u003c\/b\u003e Published rodent models, including transected Achilles tendon and medial collateral ligament studies, have reported accelerated reorganization of collagen and fibroblast migration in BPC-157-treated groups versus controls.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAngiogenesis \u0026amp; Vascular Remodeling —\u003c\/b\u003e Preclinical work has documented upregulation of VEGFR2 expression and improved capillary density in injury models, supporting investigation into BPC-157's role in tissue vascularization research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNeuroprotection —\u003c\/b\u003e Animal models of traumatic brain injury, peripheral nerve transection, and ischemic insult have reported reduced lesion progression and improved functional recovery in BPC-157 cohorts, generating ongoing interest in CNS repair research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAnti-Inflammatory Modulation —\u003c\/b\u003e Studies have measured reductions in pro-inflammatory cytokine expression and improved outcomes in colitis and arthritis models, framing BPC-157 as a candidate for investigation into systemic inflammatory responses.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with BPC-157 often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/tb500-peptides\" title=\"View TB-500 Product Page\"\u003eTB-500\u003c\/a\u003e\u003c\/b\u003e — Thymosin β4 fragment studied for cellular migration and angiogenesis; the most common pairing in published soft-tissue repair research and the basis of our Wolverine Stack (see below).\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/ghk-cu\" title=\"View GHK-Cu Product Page\"\u003eGHK-Cu\u003c\/a\u003e\u003c\/b\u003e — Copper tripeptide investigated for ECM remodeling and wound repair; complements BPC-157's cytoprotective profile with a copper-mediated gene-expression angle, and pairs with both compounds in our \u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/glow-peptide-canada\" title=\"View Glow Stack Product Page\"\u003e\u003cstrong\u003eGlow Stack.\u003c\/strong\u003e\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/bpc-157-tb-500-stack\" title=\"View Wolverine Stack Product Page\"\u003eWolverine Stack\u003c\/a\u003e\u003c\/b\u003e — Combined BPC-157 + TB-500 research blend for groups studying repair pathways in parallel.\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-retatrutide-canada\" title=\"View Retatrutide Product Page\"\u003eRetatrutide (GLP-3)\u003c\/a\u003e \u003c\/strong\u003e\u003cmeta charset=\"utf-8\"\u003e — BPC-157's activity in NAFLD and MASH models pairs with hepatic-lipid research using Retatrutide.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eHow is BPC-157 different from TB-500?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBoth are studied in tissue repair contexts but engage different pathways. BPC-157 is a 15-amino-acid pentadecapeptide derived from gastric BPC, with mechanistic work focused on nitric oxide signaling and VEGFR2-mediated angiogenesis. TB-500 is a synthetic fragment of thymosin β4 and is studied primarily for actin-binding-driven cell migration. Many research designs use them together to model complementary repair pathways.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs BPC-157 naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePartially. The 15-amino-acid sequence corresponds to a region of body protective compound, a protein identified in human gastric juice. The synthetic peptide sold for research is the isolated pentadecapeptide fragment — it does not occur as a free peptide in nature, but its sequence is drawn from a naturally occurring parent protein.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for BPC-157?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe published preclinical literature spans more than three decades and over 100 animal studies across gastrointestinal, musculoskeletal, vascular, and neural models. A 2022 pharmacokinetic study in Frontiers in Pharmacology characterized distribution and metabolism in rats and dogs. Human clinical data remain limited, with most evidence drawn from rodent and other animal models.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745392615561,"sku":null,"price":82.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg","offer_id":45745392648329,"sku":null,"price":439.99,"currency_code":"CAD","in_stock":true},{"title":"10 x 10mg (one box)","offer_id":45745392681097,"sku":null,"price":639.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/bpc-157-10mg-peptide-canada_standardized_7e837585-deaf-40ab-bf7d-f053e8e998f2.png?v=1778370991"},{"product_id":"tb500-peptides","title":"TB-500","description":"\u003ch2\u003e\u003cb\u003eBuy TB500 Peptides — Synthetic Thymosin β-4\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eTB500 peptides from Emerald Peptides supply research-grade synthetic thymosin β-4 for cellular migration, angiogenesis, and cardiac repair research designs. TB-500 is a synthetic version of the full 43-amino-acid thymosin β-4, endogenous to most mammalian cell types and one of the most extensively studied actin-binding peptides in molecular biology. Originally characterized by Allan Goldstein and colleagues in 1981, TB-500 has become a standard reference compound across cardiac repair, wound healing, and dermal regeneration research. Each TB500 vial ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₂₁₂H₃₅₀N₅₆O₇₈S \/ 4963.44 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 77591-33-4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes TB-500 a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eThymosin β-4 was first isolated from calf thymic tissue in 1981 by Allan Goldstein and colleagues, with subsequent decades of research expanding its role beyond the immune system to include broad tissue-repair and cytoskeletal-regulation functions. The synthetic 43-amino-acid form, popularized as TB-500 in research and veterinary contexts, became a standard tool for groups studying actin dynamics in vivo.\u003c\/p\u003e\n\u003cp\u003eWhat distinguishes TB-500 from other repair-focused peptides is its mechanistic specificity. By acting as the principal G-actin sequestering peptide, it provides researchers with a defined molecular handle on cytoskeletal organization — a starting point for downstream investigation of cell migration, angiogenic transcriptional programs, and tissue regeneration. Its activity across endothelial, fibroblast, keratinocyte, and cardiomyocyte systems makes it one of the few peptide tools relevant across multiple parallel research domains.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eCellular Migration \u0026amp; Wound Repair —\u003c\/b\u003e Published in vitro and rodent studies report accelerated keratinocyte migration, fibroblast recruitment, and re-epithelialization kinetics in TB-500-treated wound models, with mechanistic work linking effects to G-actin sequestration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAngiogenesis \u0026amp; Vascular Remodeling —\u003c\/b\u003e Animal models have documented increased capillary density and endothelial cell organization in dermal and cardiac tissue, supporting investigation into TB-500's role in vascularization research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCardiac Tissue Models —\u003c\/b\u003e Preclinical studies in murine ischemia-reperfusion models have reported reduced infarct size and improved cardiomyocyte survival, generating sustained interest in TB-500 as a tool peptide for cardiac repair research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSkeletal Muscle \u0026amp; Soft Tissue Repair —\u003c\/b\u003e Published rodent injury models, including muscle crush and tendon laceration designs, describe accelerated recovery markers and improved tissue organization in treated cohorts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAnti-Inflammatory Modulation —\u003c\/b\u003e Cell-based and animal studies have measured reductions in inflammatory cytokine expression and modulation of NF-κB signaling, framing TB-500 as a candidate for investigation into inflammation-coupled tissue repair.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with TB-500 often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Gastric pentadecapeptide studied for nitric-oxide-mediated cytoprotection and VEGFR2-driven angiogenesis; the most common pairing in published soft-tissue repair research, formalized in our Wolvering Stack (see below).\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/ghk-cu\" title=\"View GHK-Cu Product Page\"\u003eGHK-Cu\u003c\/a\u003e\u003c\/b\u003e — Copper tripeptide investigated for ECM remodeling and gene-expression modulation; complements TB-500's cytoskeletal mechanism with a copper-mediated repair angle, and pairs with both compounds in our \u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/glow-peptide-canada\" title=\"View Glow Stack Product Page\"\u003e\u003cstrong\u003eGlow Stack.\u003c\/strong\u003e\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/bpc-157-tb-500-stack\" title=\"View Wolverine Stack Product Page\"\u003eWolverine Stack\u003c\/a\u003e\u003c\/b\u003e — Combined BPC-157 + TB-500 research blend for groups studying repair pathways in parallel.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-retatrutide-canada\" title=\"View Retatrutide Product Page\"\u003e\u003cstrong\u003eRetatrutide (GLP-3)\u003c\/strong\u003e\u003c\/a\u003e \u003cmeta charset=\"utf-8\"\u003e — TB-500's cardiac-research literature complements cardiometabolic designs incorporating Retatrutide.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eIs TB-500 the same as thymosin β-4?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eFunctionally, yes — TB-500 sold as a research peptide is a synthetic version of the full 43-amino-acid thymosin β-4 sequence. The TB-500 designation originated in veterinary and research contexts, while \"thymosin β-4\" is the original biochemical name. Note that some suppliers sell a much shorter 7-amino-acid fragment (Ac-LKKTETQ) under the TB-500 name; ours is the full 43-aa peptide.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is TB-500 different from BPC-157?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBoth are studied in tissue repair contexts but engage different mechanisms. TB-500 acts on the actin cytoskeleton via G-actin sequestration, regulating cell migration and angiogenesis. BPC-157 is a 15-amino-acid pentadecapeptide derived from gastric BPC, with mechanistic work focused on nitric oxide signaling and VEGFR2-mediated vascular remodeling. Many research designs use them together to model complementary repair pathways.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for TB-500?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe thymosin β-4 literature spans more than four decades, with hundreds of cell-based and animal studies across wound healing, cardiac repair, neural regeneration, and inflammation models. Mechanistic studies have characterized actin-binding kinetics and downstream signaling. Clinical-stage human data remain limited; the bulk of evidence sits in rodent, large-animal, and cell-system research.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745396842633,"sku":null,"price":89.99,"currency_code":"CAD","in_stock":true},{"title":"6x10mg","offer_id":45745396875401,"sku":null,"price":479.99,"currency_code":"CAD","in_stock":true},{"title":"10x10mg (one box)","offer_id":45745396908169,"sku":null,"price":649.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/tb-500-10mg-peptide-canada_standardized.png?v=1778370915"},{"product_id":"buy-melanotan-2-canada","title":"Melanotan II (MT-2)","description":"\u003ch2\u003e\u003cb\u003eBuy Melanotan 2 Canada — Synthetic α-MSH Analog\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy Melanotan 2 in Canada as a research-grade synthetic melanocortin agonist for pigmentation, appetite, and sexual response research designs. Melanotan 2 (MT-2) is a synthetic cyclic heptapeptide analog of α-melanocyte-stimulating hormone (α-MSH), originally developed at the University of Arizona in the 1980s. The compound acts as a non-selective agonist across multiple melanocortin receptors (MC1R through MC5R), giving research designs broad pharmacological access to melanocortin biology. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₅₀H₆₉N₁₅O₉ \/ 1024.18 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 121062-08-6\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes Melanotan 2 a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eMelanotan 2 was developed at the University of Arizona by Victor Hruby and colleagues in the late 1980s as part of a structure-activity program designed to produce metabolically stable α-MSH analogs. The key innovations — replacement of methionine with norleucine, substitution of L-phenylalanine with its D-enantiomer, and lactamization between aspartic acid and lysine to lock the peptide into its bioactive conformation — produced a compound with substantially extended half-life and full agonist activity at multiple melanocortin receptors.\u003c\/p\u003e\n\u003cp\u003eWhat distinguishes Melanotan 2 from later melanocortin tools is its broad receptor profile. Where bremelanotide (PT-141) shows preferential activity at MC4R, Melanotan 2 acts as a non-selective agonist across MC1R, MC3R, MC4R, and MC5R — making it a useful reference compound for groups dissecting receptor-specific contributions to melanocortin pathway phenotypes.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003ePigmentation \u0026amp; Melanogenesis —\u003c\/b\u003e MC1R activation in melanocyte models drives eumelanin synthesis through cAMP-PKA-MITF signaling. Published cell and animal studies have measured dose-dependent increases in melanin content following Melanotan 2 exposure, supporting its use as a reference tool in pigmentation research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAppetite \u0026amp; Energy Balance —\u003c\/b\u003e Hypothalamic MC3R and MC4R activation has been studied for its role in feeding suppression. Rodent models have reported reduced food intake across multiple hyperphagia paradigms following intracerebroventricular Melanotan 2 administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eMelanocortin Receptor Pharmacology —\u003c\/b\u003e As a non-selective full agonist, Melanotan 2 serves as a baseline tool compound in receptor-deconvolution studies where researchers compare its profile against subtype-selective agonists and antagonists.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eUV Photoprotection Research —\u003c\/b\u003e Eumelanin produced via MC1R activation absorbs UV radiation, and Melanotan 2 has been investigated in animal models as a tool for studying tan-mediated photoprotection independent of UV exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSexual Response Circuitry —\u003c\/b\u003e MC3R\/MC4R activation in CNS pathways has been examined in animal models of sexual response, with Melanotan 2 preceding the development of more receptor-selective compounds in this research area.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with Melanotan 2 often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/pt-141\" title=\"View PT-141 Product Page\"\u003ePT-141\u003c\/a\u003e\u003c\/b\u003e — Bremelanotide, an MC3R\/MC4R-preferring melanocortin agonist; the standard mechanistic contrast for Melanotan 2 in receptor-selectivity studies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/ghk-cu\" title=\"View GHK-Cu Product Page\"\u003eGHK-Cu\u003c\/a\u003e\u003c\/b\u003e — Copper tripeptide investigated for ECM remodeling and skin biology; complements Melanotan 2's pigmentation focus with a separate copper-mediated dermal-research angle.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"file:\/\/\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Pentadecapeptide studied for cytoprotection and tissue repair; pairs with Melanotan 2 in dermal-research designs spanning pigmentation and repair endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy Melanotan 2 in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur Melanotan 2 ships to Canadian research labs and independent investigators with a batch-specific certificate of analysis confirming ≥99% HPLC purity and mass-spec identity verification. Vials are filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution work, and ship from within Canada to avoid border-related cold-chain interruptions.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is Melanotan 2 different from PT-141?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBoth are α-MSH-derived melanocortin agonists, but they differ in receptor selectivity. Melanotan 2 is a non-selective full agonist across MC1R, MC3R, MC4R, and MC5R, making it active in pigmentation, appetite, and sexual-response research. PT-141 (bremelanotide) shows preferential activity at MC3R and MC4R, with reduced MC1R engagement, which is why it became the focus of CNS-mediated sexual response research while Melanotan 2 remained a broader pigmentation and melanocortin-pathway tool.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs Melanotan 2 naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. Melanotan 2 is a synthetic cyclic heptapeptide engineered as a stable analog of α-MSH, the natural melanocortin hormone that consists of a 13-amino-acid linear sequence. The structural modifications — D-phenylalanine substitution, norleucine for methionine, and the Asp-Lys lactam bridge — are deliberately non-natural and confer the metabolic stability that endogenous α-MSH lacks.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for Melanotan 2?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe published preclinical literature spans more than three decades, beginning with foundational structure-activity work from Hruby and colleagues at the University of Arizona in the late 1980s and 1990s. Subsequent cell and animal studies have characterized melanogenesis, appetite, and CNS effects across multiple model systems. Pilot human clinical data exist but Melanotan 2 has not received approval from any major regulatory agency for human use.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️\u003cem\u003e For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745407656073,"sku":null,"price":44.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg","offer_id":45745407688841,"sku":null,"price":259.99,"currency_code":"CAD","in_stock":true},{"title":"10 x 10mg (one box)","offer_id":45745407721609,"sku":null,"price":399.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/melanotan-II-MT-2-10mg-peptide-canada_standardized_147a9c06-3f6e-4f61-ae0d-378bf259f4fc.png?v=1778370884"},{"product_id":"buy-mots-c-canada","title":"MOTS-c","description":"\u003ch2\u003e\u003cb\u003eBuy MOTS-c Canada — Mitochondrial-Derived Peptide\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy MOTS-c in Canada as a research-grade mitochondria-derived peptide for cellular bioenergetics, AMPK signaling, and mitochondrial research designs. MOTS-c is a 16-amino-acid peptide encoded within the 12S rRNA region of mitochondrial DNA — one of only a handful of peptides known to originate from the mitochondrial genome rather than nuclear DNA. Identified in 2015 by Changhan Lee and colleagues at the USC Davis School of Gerontology, MOTS-c acts as a mitochondrial-nuclear retrograde signal that activates AMPK and shifts cellular substrate handling toward fatty acid oxidation. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₁₀₁H₁₅₂N₂₈O₂₂S₂ \/ 2174.64 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 1627580-64-6\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes MOTS-c a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eMOTS-c was identified in 2015 by Changhan Lee and colleagues in the Pinchas Cohen laboratory at the USC Davis School of Gerontology, with the original characterization published in Cell Metabolism. Its discovery extended the small but growing class of mitochondrial-derived peptides — a category that began with humanin in 2001 — and challenged the long-held view that the 12S rRNA gene region produced no functional peptides.\u003c\/p\u003e\n\u003cp\u003eWhat distinguishes MOTS-c from other research compounds is its origin. Unlike nuclear-encoded peptides translated within the cell's main protein-synthesis machinery, MOTS-c's coding sequence sits inside mitochondrial DNA, with translation occurring in the cytoplasm using the standard genetic code. The first 11 residues are highly conserved across 14 species, suggesting strong evolutionary pressure on its function. This combination — mitochondrial origin, cross-species conservation, AMPK-pathway activity — gives researchers a unique tool for probing the bioenergetic-signaling axis between mitochondria and the rest of the cell.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eInsulin Sensitivity \u0026amp; Glucose Metabolism —\u003c\/b\u003e Published animal studies have reported improved skeletal muscle glucose uptake and insulin sensitivity following MOTS-c administration, with mechanistic work attributing the effect to AMPK pathway activation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAdiposity \u0026amp; Body Composition —\u003c\/b\u003e Rodent studies of high-fat-diet-induced obesity have measured reductions in body fat mass and improved metabolic parameters in MOTS-c-treated cohorts, generating sustained interest in the peptide as a research tool for metabolic-syndrome models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eExercise Mimetic \u0026amp; Endurance —\u003c\/b\u003e MOTS-c is upregulated in response to exercise, and rodent endurance studies have reported improved running capacity and metabolic flexibility in treated animals — supporting its characterization as an endogenous exercise mimetic.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAging \u0026amp; Longevity —\u003c\/b\u003e Plasma MOTS-c levels decline with age in published human and animal data, and mid-life administration in mouse models has been examined for effects on healthspan markers, drawing interest from longevity research groups.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eMitochondrial Bioenergetics —\u003c\/b\u003e As a mitochondrial-nuclear retrograde signal, MOTS-c serves as a research handle on inter-organelle communication, with studies measuring effects on substrate oxidation, mitochondrial biogenesis markers, and bioenergetic flexibility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with MOTS-c often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-ss-31\" title=\"View SS-31 Product Page\"\u003eSS-31\u003c\/a\u003e\u003c\/b\u003e — Tetrapeptide that targets cardiolipin on the inner mitochondrial membrane; complements MOTS-c's signaling activity with a structural mitochondrial-stabilization mechanism, and pairs with both compounds in our Mito Stack (see below).\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/nad-plus\" title=\"View NAD+ Product Page\"\u003eNAD+\u003c\/a\u003e\u003c\/b\u003e — Mitochondrial cofactor central to sirtuin signaling and redox balance; the third compound in the Mito Stack and a frequent companion in bioenergetics research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/mots-c-ss31-nad-stack\" title=\"View Mito Stack Product Page\"\u003eMito Stack\u003c\/a\u003e\u003c\/b\u003e — Combined MOTS-c + SS-31 + NAD+ research blend for groups studying mitochondrial function across signaling, structural, and cofactor mechanisms in parallel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy MOTS-c in Canada with verified purity documentation?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur MOTS-c ships to Canadian research labs and independent investigators with a batch-specific certificate of analysis confirming ≥99% HPLC purity and mass-spec identity verification. Vials are filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution work, and ship from within Canada to avoid border-related cold-chain interruptions.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is MOTS-c different from SS-31?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBoth are mitochondrial-focused peptides but engage entirely different mechanisms. MOTS-c is a 16-amino-acid signaling peptide encoded within mitochondrial DNA; it activates AMPK and acts as a mitochondrial-nuclear retrograde messenger. SS-31 (elamipretide) is a synthetic tetrapeptide that binds cardiolipin on the inner mitochondrial membrane to stabilize cristae structure and reduce reactive oxygen species production. Many research designs use them together to address mitochondrial function from both signaling and structural angles.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs MOTS-c naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eYes. MOTS-c is endogenous in humans and most mammals, encoded by the MT-RNR1 gene within the mitochondrial 12S rRNA region. It is detectable in plasma in both rodents and humans, with levels that decline with age. The synthetic peptide sold for research is sequence-identical to the endogenous form.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for MOTS-c?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eSince the original 2015 Cell Metabolism characterization, the published literature has expanded to cover insulin sensitivity, body composition, exercise capacity, aging biomarkers, and inflammatory and host-defense functions. Animal model data are well-developed across rodent systems. Human clinical data remain limited, with most evidence drawn from preclinical work and observational studies of endogenous MOTS-c levels.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️\u003cem\u003e For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745410736265,"sku":null,"price":59.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg","offer_id":45745410769033,"sku":null,"price":319.99,"currency_code":"CAD","in_stock":true},{"title":"10 x 10mg (one box)","offer_id":45745410801801,"sku":null,"price":499.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/mots-c-10mg-peptide-canada_standardized_0761b4f8-19c9-40f5-a0fc-c60fce134492.png?v=1778370793"},{"product_id":"buy-tesamorelin-canada","title":"Tesamorelin","description":"\u003ch2\u003e\u003cb\u003eBuy Tesamorelin Canada — Synthetic GHRH(1-44) Analog\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy Tesamorelin in Canada as a research-grade GHRH analog for somatotropic axis, lean mass, and visceral adiposity research designs. Tesamorelin is a synthetic 44-amino-acid analog of growth-hormone-releasing hormone (GHRH), engineered with an N-terminal trans-3-hexenoic acid modification that confers resistance to DPP-IV cleavage. Developed by Montreal-based Theratechnologies and approved by the FDA in 2010 under the brand name Egrifta for visceral adiposity in HIV-associated lipodystrophy, Tesamorelin remains the only GHRH analog to receive regulatory approval. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₂₂₁H₃₆₆N₇₂O₆₇S \/ ~5135.9 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 218949-48-5\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes Tesamorelin a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eTesamorelin was developed by Theratechnologies, Inc., a Montreal-based biotech, and remains the only GHRH analog to receive FDA approval — granted in 2010 for visceral adiposity reduction in HIV-associated lipodystrophy under the brand name Egrifta. That clinical track gives researchers a published human pharmacokinetic, pharmacodynamic, and safety dataset most research peptides cannot match.\u003c\/p\u003e\n\u003cp\u003eStructurally, Tesamorelin retains the full 44-amino-acid hGHRH sequence, distinguishing it from shorter GHRH fragments like sermorelin (GHRH 1-29). The trans-3-hexenoic acid moiety attached to the N-terminal tyrosine extends half-life by blocking DPP-IV cleavage at the Tyr¹-Ala² bond, the primary degradation site for native GHRH. Among Canadian research compounds with a documented clinical trail, Tesamorelin sits in a small group of GHRH-axis tools available for laboratory investigation.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eGH\/IGF-1 Axis Activation —\u003c\/b\u003e Tesamorelin elicits pulsatile GH secretion through GHRHR agonism, with downstream IGF-1 elevation observed across published preclinical and clinical pharmacodynamic studies — making it a reference tool for somatotropic-axis investigation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eLean Mass \u0026amp; Anabolic Research —\u003c\/b\u003e GH and IGF-1 elevation drive protein synthesis and skeletal muscle anabolism in published animal models, supporting Tesamorelin's use in research designs comparing GH-axis activation against alternative anabolic peptide mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eVisceral Adiposity —\u003c\/b\u003e Phase 3 clinical trials demonstrated dose-dependent reductions in visceral adipose tissue, mediated through GH-stimulated hormone-sensitive lipase activity. The dataset gives researchers a uniquely well-characterized human reference for GH-driven lipolysis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eLipid Metabolism \u0026amp; Cardiometabolic Markers —\u003c\/b\u003e Published trials have measured improvements in triglyceride profiles and adiponectin alongside VAT reduction, generating sustained interest in Tesamorelin as a tool for cardiometabolic-pathway research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCognitive Aging Research —\u003c\/b\u003e Randomized studies have explored Tesamorelin's effects on cognitive markers and brain GABA\/myo-inositol ratios in older adults, opening a parallel research direction beyond its primary metabolic indication.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with Tesamorelin often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-retatrutide-canada\" title=\"View Retatrutide Product Page\"\u003eRetatrutide\u003c\/a\u003e\u003c\/b\u003e — Triple GLP-1\/GIP\/glucagon agonist; provides a clean mechanistic contrast to GH-axis-driven body composition effects in metabolic-research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-mots-c-canada\" title=\"View MOTS-c Product Page\"\u003eMOTS-c\u003c\/a\u003e\u003c\/b\u003e — Mitochondria-derived peptide investigated for insulin sensitivity and exercise-mimetic activity; complements Tesamorelin's endocrine angle with cellular-energetics research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Pentadecapeptide studied for tissue repair and cytoprotection; pairs with Tesamorelin in research designs combining anabolic signaling and recovery endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy Tesamorelin in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur Tesamorelin ships to Canadian research labs and independent investigators with a batch-specific certificate of analysis confirming ≥99% HPLC purity and mass-spec identity verification. Vials are filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution work, and ship from within Canada to avoid border-related cold-chain interruptions. Tesamorelin was originally developed in Canada by Theratechnologies, giving it a notable connection to Canadian peptide research.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is Tesamorelin different from sermorelin or CJC-1295?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eSermorelin is a truncated GHRH(1-29) fragment with a much shorter half-life. CJC-1295 is also based on GHRH(1-29) but adds amino acid substitutions (and, in DAC variants, a maleimidopropionic acid linker for albumin binding). Tesamorelin retains the full GHRH(1-44) sequence with N-terminal lipid modification, giving it both DPP-IV resistance and the full receptor-binding domain of native GHRH — a different structural strategy from the truncated analogs.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs Tesamorelin naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePartially. The 44-amino-acid sequence corresponds to native human GHRH, an endogenous hypothalamic peptide. The N-terminal trans-3-hexenoic acid modification is synthetic and does not occur in nature; it is added specifically to extend metabolic stability for research and clinical use.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for Tesamorelin?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eTesamorelin has the most developed evidence base of any GHRH analog. Phase 3 clinical trials in HIV-associated lipodystrophy supported its 2010 FDA approval, with published data on visceral fat reduction, IGF-1 elevation, lipid profiles, and tolerability. Subsequent research has examined cognitive aging, NAFLD, and broader metabolic endpoints.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745412472969,"sku":null,"price":84.99,"currency_code":"CAD","in_stock":true},{"title":"6x10mg","offer_id":45745412505737,"sku":null,"price":489.99,"currency_code":"CAD","in_stock":true},{"title":"10x10mg (one box)","offer_id":45745412538505,"sku":null,"price":749.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/tesamorelin-10mg-peptide-canada_standardized.png?v=1778370746"},{"product_id":"bacteriostatic-water-canada","title":"Bacteriostatic Water (BAC) - 30mL","description":"\u003ch2\u003e\u003cb\u003eBacteriostatic Water Canada — 30 mL Sterile USP-Grade Vials\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBacteriostatic water Canada-shipped from Emerald Peptides supplies USP-grade sterile water with 0.9% benzyl alcohol preservative for research peptide reconstitution and laboratory diluent applications. Bacteriostatic water is the standard reconstitution diluent for lyophilized research peptides in multi-dose use contexts, with the benzyl alcohol providing bacteriostatic activity that allows multiple withdrawals from a single vial over extended periods. Each 30 mL vial is filled to label, sealed under aseptic conditions, and shipped domestically across Canada with reliable cold-chain handling. The product is supplied for research use only.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Sterile aqueous solution\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 30 mL multi-dose vial\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eBacteriostatic agent:\u003c\/b\u003e 0.9% benzyl alcohol (USP standard)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSterility:\u003c\/b\u003e Sterile-filtered, sealed under aseptic conditions\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eContainer:\u003c\/b\u003e Multi-dose vial with rubber stopper\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e Room temperature, protect from freezing\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eGrade:\u003c\/b\u003e USP \/ research grade\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Bacteriostatic Water Is and What It Isn't\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eBacteriostatic water is a defined USP monograph product: water for injection with 0.9% (9 mg\/mL) benzyl alcohol added as a preservative. Benzyl alcohol inhibits bacterial growth without sterilizing the solution outright — meaning the vial remains microbiologically stable across repeated punctures of the rubber stopper for the period defined by the manufacturer (typically 28 days from first puncture under standard handling).\u003c\/p\u003e\n\u003cp\u003eWhat bacteriostatic water isn't: it isn't sterile water for injection (no preservative, single-use), it isn't normal saline (no sodium chloride), and it isn't a buffered solution (no pH-adjusting agents). For laboratory peptide reconstitution work where the same vial of lyophilized compound is drawn from multiple times, bacteriostatic water is the standard diluent because it matches the multi-dose use case. For single-use applications or for compounds that interact unfavorably with benzyl alcohol, sterile water for injection is the alternative.\u003c\/p\u003e\n\u003cp\u003eAmong Canadian research laboratories, sourcing decisions for bacteriostatic water typically come down to three factors: USP-grade compliance, vial size matched to typical workflow (30 mL is the most common multi-dose research format), and supply-chain reliability. Our BAC water meets the USP monograph specification, ships from within Canada to avoid border-related interruptions, and is supplied with batch documentation on request.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eQuality \u0026amp; Supply Specifications\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eUSP Monograph Compliance —\u003c\/b\u003e The 0.9% benzyl alcohol concentration matches the USP bacteriostatic water for injection monograph, the reference specification used in research and clinical supply contexts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eMulti-Dose Vial Format —\u003c\/b\u003e 30 mL is the standard research-laboratory format. Larger than the 10 mL clinical format, it supports extended reconstitution work across multiple lyophilized compounds without requiring frequent vial changes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSterile-Filtered Manufacturing —\u003c\/b\u003e Each vial is filled under aseptic conditions through 0.22 µm sterile filtration. Vial integrity is maintained until first puncture of the rubber stopper.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCanadian Supply Chain —\u003c\/b\u003e Orders dispatch from within Canada, avoiding border customs delays and the temperature variations associated with international shipping. This matters less for BAC water than for lyophilized peptides, but matters for delivery time.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Compounds\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers sourcing bacteriostatic water typically order it alongside lyophilized research peptides:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca title=\"Shop BPC-157\" href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Pentadecapeptide for tissue repair research; one of the most frequently reconstituted compounds in Canadian peptide research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca title=\"Shop TB-500\" href=\"https:\/\/emeraldpeptides.ca\/products\/tb500-peptides\"\u003eTB-500\u003c\/a\u003e\u003c\/b\u003e — Synthetic thymosin β-4 for cellular migration and angiogenesis research; commonly reconstituted alongside BPC-157 in repair-research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/bpc-157-tb-500-stack\" title=\"View Wolverine Stack Product Page\"\u003eWolverine Stack\u003c\/a\u003e\u003c\/b\u003e — Combined BPC-157 + TB-500 research kit; standard pairing with multi-dose BAC water for parallel-pathway repair research.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the difference between bacteriostatic water and sterile water for injection?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe defining difference is the 0.9% benzyl alcohol preservative. Sterile water for injection contains only water — no preservatives — and is single-use after the vial is opened, because nothing inhibits microbial growth once the seal is broken. Bacteriostatic water contains 0.9% benzyl alcohol, which inhibits bacterial growth and allows the vial to be punctured multiple times across an extended period (typically 28 days from first puncture under standard handling). For multi-dose laboratory peptide reconstitution work, BAC water is the standard diluent.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs bacteriostatic water the same as saline?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. Saline contains 0.9% sodium chloride and is used for tonicity-matched applications. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative and contains no sodium chloride. The two are not interchangeable — research protocols specify one or the other based on the requirements of the compound being reconstituted and the experimental design.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is BAC water stored?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBacteriostatic water is stored at room temperature and should not be frozen. The vial remains sealed and microbiologically stable until first puncture, after which it is typically used within 28 days under standard handling. Refer to the manufacturer's labeling for batch-specific stability windows. Our BAC water ships from within Canada under standard ambient conditions, with no cold-chain requirements.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"Default Title","offer_id":45722781483145,"sku":null,"price":24.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/bacteriostatic-water-BAC-30ml-peptide-canada_standardized_69df3048-d45f-4363-9558-128e9933bed8.png?v=1778371081"},{"product_id":"semax","title":"Semax","description":"\u003ch2\u003e\u003cb\u003eSemax — Synthetic ACTH(4-10) Analog\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003cmeta charset=\"utf-8\"\u003eBuy Semax in Canada as a research-grade synthetic peptide for nootropic, neuroprotective, and BDNF-modulation research designs. Semax is a synthetic heptapeptide analog of ACTH(4-10), originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and approved for clinical use in Russia and Ukraine for ischemic stroke and post-stroke neurorehabilitation. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₃₇H₅₁N₉O₁₀S \/ 813.92 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 80714-61-0\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes Semax a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eSemax was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences — the same institute that produced its sister compound Selank — and is approved for human clinical use in Russia for ischemic stroke, optic nerve disorders, and post-stroke neurorehabilitation. That clinical track gives Semax a published human dataset that few regulatory peptides circulating in Western research markets can match.\u003c\/p\u003e\n\u003cp\u003eStructurally, Semax retains the ACTH(4-7) tetrapeptide core but deliberately omits the Arg-Trp-Gly residues that would otherwise confer melanocortin receptor activity. The result is a compound with the neurotrophic and cognitive-modulatory effects of ACTH-derived peptides, decoupled from the pigmentary and steroidogenic activity of native ACTH or melanocortin agonists — making Semax a clean tool for groups studying neurotrophin pathways without confounding melanocortin receptor engagement.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eNootropic \u0026amp; Cognitive Research —\u003c\/b\u003e Rodent studies have measured rapid elevation of hippocampal BDNF and TrkB expression following Semax exposure, alongside improved performance in learning, memory, and attention paradigms — supporting its use as a reference tool in neurotrophin-mediated cognitive research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNeuroprotection in Ischemia —\u003c\/b\u003e Published rat models of permanent middle cerebral artery occlusion and global ischemia have reported reduced infarct progression, attenuated cortical nitric oxide overproduction, and modulated immune-response gene expression in Semax-treated cohorts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNeurotrophin Pathway Modulation —\u003c\/b\u003e Beyond BDNF, Semax has been examined for effects on NGF expression and TrkA signaling, framing it as a broad-spectrum neurotrophin-pathway research tool.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAnxiolytic \u0026amp; Stress Response —\u003c\/b\u003e Animal models have measured increased open-arm time in elevated plus-maze paradigms and attenuated stress-induced behavioral disruption in Semax-treated rodents.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCopper-Binding \u0026amp; Aβ Aggregation —\u003c\/b\u003e Recent biochemical studies have characterized Semax's ability to form stable complexes with copper(II) ions in an albumin-like coordination mode, with downstream effects on copper-induced amyloid-β aggregation in neuronal cell models.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with Semax often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca title=\"View Selank Product Page\" href=\"https:\/\/emeraldpeptides.ca\/products\/selank\"\u003eSelank\u003c\/a\u003e\u003c\/b\u003e — The sister regulatory heptapeptide developed at the same Russian institute; Selank targets GABAergic and immunomodulatory pathways for anxiolytic research, complementing Semax's BDNF-driven cognitive and neuroprotective profile in CNS research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca title=\"View BPC-157 Product Page\" href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Pentadecapeptide with documented neuroprotective activity in rodent models of TBI and peripheral nerve injury; pairs with Semax in research designs spanning CNS repair, nerve regeneration, and cytoprotection endpoints.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca title=\"View Tesamorelin Product Page\" href=\"https:\/\/emeraldpeptides.ca\/products\/buy-tesamorelin-canada\"\u003eTesamorelin\u003c\/a\u003e\u003c\/b\u003e — GHRH analog with published cognitive-aging research data, including effects on brain GABA and myo-inositol ratios; provides a complementary mechanism for groups studying peptide-mediated cognitive function across endocrine and regulatory-peptide axes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\n\u003cb\u003eWhy source Semax from a Canadian peptides su\u003c\/b\u003e\u003cb\u003epplier?\u003c\/b\u003e\n\u003c\/h3\u003e\n\u003cp\u003eSourcing within Canada means shorter cold-chain transit and no cross-border customs interruptions, both of which matter for lyophilized peptides shipped to research labs. Our Semax is supplied with batch-specific certificates of analysis confirming ≥99% HPLC purity and mass-spec identity verification, and vials are filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is Semax different from Selank?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBoth are synthetic heptapeptide regulatory peptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, but they target different research domains. Semax is an ACTH(4-10) analog studied primarily for nootropic, neuroprotective, and BDNF-modulating effects in cognitive and ischemic-injury research. Selank is a tuftsin analog studied primarily for anxiolytic and immunomodulatory effects via GABAergic and enkephalin-stabilization pathways. Many research designs use them in parallel to address cognitive and neuro-immune endpoints simultaneously.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs Semax naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. Semax is fully synthetic. Its core sequence corresponds to amino acids 4–7 of the endogenous adrenocorticotropic hormone (ACTH), but the full Met-Glu-His-Phe-Pro-Gly-Pro heptapeptide does not occur in nature — the C-terminal Pro-Gly-Pro extension is engineered to confer metabolic stability beyond what native ACTH fragments achieve.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow does Semax differ from native ACTH or melanocortin agonists?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNative ACTH(4-10) contains the Arg-Trp-Gly motif required for melanocortin receptor activation. Semax deliberately omits these residues, retaining only the ACTH(4-7) core plus the Pro-Gly-Pro extension. This produces a compound with neurotrophic and cognitive activity independent of melanocortin receptor engagement, distinguishing it cleanly from peptides like Melanotan 2 or PT-141.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️\u003cem\u003e For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745418371209,"sku":null,"price":64.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg","offer_id":45745418403977,"sku":null,"price":329.99,"currency_code":"CAD","in_stock":true},{"title":"10 x 10mg (one box)","offer_id":45745418436745,"sku":null,"price":429.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/semax-10mg-peptide-canada_standardized.png?v=1778370681"},{"product_id":"selank","title":"Selank","description":"\u003ch2\u003e\u003cb\u003eSelank — Synthetic Tuftsin Analog\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy Selank in Canada as a research-grade synthetic peptide for anxiolytic, immunomodulatory, and GABAergic research designs. Selank is a synthetic heptapeptide analog of the endogenous immunomodulator tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and approved for clinical use in Russia and Ukraine for generalized anxiety disorder. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₃₃H₅₇N₁₁O₉ \/ 751.88 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 129954-34-3\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes Selank a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eSelank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in collaboration with the V.V. Zakusov Research Institute of Pharmacology, and is approved for human clinical use as an anxiolytic in Russia and Ukraine — a regulatory profile that distinguishes it from most synthetic regulatory peptides circulating in Western research markets. Its parent compound, tuftsin, is a four-amino-acid fragment of the IgG heavy chain Fc region with documented immunomodulatory activity.\u003c\/p\u003e\n\u003cp\u003eThe structural innovation in Selank is the C-terminal Pro-Gly-Pro tripeptide. This extension shields tuftsin from enzymatic cleavage and produces a peptide that retains the parent's immunoregulatory profile while adding well-characterized anxiolytic and cognitive activity. Among research peptides operating at the neuro-immune interface, Selank is one of the few tools with both a developed clinical dataset and a clear mechanistic profile spanning GABAergic, monoaminergic, and enkephalin-pathway endpoints.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eAnxiolytic \/ GABAergic Modulation —\u003c\/b\u003e Rodent studies have measured increased amplitude and discharge rate of inhibitory postsynaptic currents in hippocampal CA1 neurons following Selank exposure, supporting investigation into GABAergic-mediated anxiety models without the dependence profile associated with benzodiazepine tools.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNootropic \u0026amp; Cognitive Research —\u003c\/b\u003e Published animal models have reported improvements in learning, memory consolidation, and orientational-investigative behavior, with mechanistic work linking effects to BDNF expression and serotonin metabolism modulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eImmune \u0026amp; Cytokine Modulation —\u003c\/b\u003e Selank has been characterized in animal studies as a modulator of IL-6 expression and T-helper cell cytokine balance, retaining the immunoregulatory profile of its tuftsin parent compound.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eEnkephalin Stabilization \u0026amp; Opioid Withdrawal Research —\u003c\/b\u003e Preclinical work has examined Selank's inhibition of enkephalin degradation in models of morphine withdrawal, with rat studies measuring attenuation of aversive withdrawal signs following administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStress Response —\u003c\/b\u003e Animal studies of acute stress have reported reduced affective response and decreased erroneous escape attempts in Selank-treated cohorts, framing the peptide as a research tool for HPA-axis and behavioral stress paradigms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with Selank often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/semax\" title=\"View Semax Product Page\"\u003eSemax\u003c\/a\u003e\u003c\/b\u003e — The sister regulatory heptapeptide developed at the same Russian institute; Semax targets BDNF\/NGF pathways for cognitive and neuroprotective research, complementing Selank's anxiolytic and immunomodulatory profile in CNS research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Pentadecapeptide with documented anxiolytic and gut-brain-axis activity in rodent models; pairs with Selank in research designs probing the intersection of GI biology, stress response, and behavioral endpoints.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-tesamorelin-canada\" title=\"View Tesamorelin Product Page\"\u003eTesamorelin\u003c\/a\u003e\u003c\/b\u003e — GHRH analog with published cognitive-aging research data; provides a complementary mechanism for groups studying peptide-mediated cognitive function across endocrine and regulatory-peptide axes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhy source Selank from a Canadian peptides CA supplier?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eSourcing within Canada means shorter cold-chain transit and no cross-border customs interruptions, both of which matter for lyophilized peptides shipped to research labs. Our Selank is supplied with batch-specific certificates of analysis confirming ≥99% HPLC purity and mass-spec identity verification, and vials are filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is Selank different from Semax?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBoth are synthetic heptapeptide regulatory peptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, but they target different research domains. Selank is a tuftsin analog studied primarily for anxiolytic and immunomodulatory effects, with documented activity in GABAergic and enkephalin-stabilization research. Semax is an ACTH(4–10) analog studied primarily for BDNF\/NGF-mediated cognitive and neuroprotective research. Many research designs use them in parallel to address neuro-immune and cognitive endpoints simultaneously.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs Selank naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe parent peptide, tuftsin (Thr-Lys-Pro-Arg), is a naturally occurring tetrapeptide produced from immunoglobulin G heavy chain cleavage. Selank itself, with its C-terminal Pro-Gly-Pro extension, is fully synthetic — the seven-amino-acid sequence does not occur in nature, and the extension was deliberately engineered to extend the metabolic stability of the native tuftsin fragment.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for Selank?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eSelank has been studied extensively in Russian and international preclinical literature since the 1990s, with characterized effects across anxiety, cognition, immune modulation, and opioid-withdrawal models. It is approved for human anxiolytic use in Russia and Ukraine, providing a clinical dataset most regulatory peptides lack. Mechanistic work has implicated GABAergic, serotonergic, BDNF-pathway, and enkephalinase-inhibition contributions.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":45745419878537,"sku":null,"price":39.99,"currency_code":"CAD","in_stock":false},{"title":"6 x 10mg","offer_id":45745419911305,"sku":null,"price":229.99,"currency_code":"CAD","in_stock":false},{"title":"10 x 10mg (one box)","offer_id":45745419944073,"sku":null,"price":349.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/selank-10mg-peptide-canada_standardized.png?v=1778369123"},{"product_id":"pt-141","title":"PT-141","description":"\u003ch2\u003e\u003cb\u003ePT-141 — Melanocortin Receptor Agonist\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy PT-141 in Canada as a research-grade melanocortin receptor agonist for CNS sexual response, neuropharmacology, and MC3R\/MC4R research designs. PT-141 (also known by the international nonproprietary name bremelanotide) is a synthetic cyclic heptapeptide originally derived from Melanotan II, developed by Palatin Technologies and approved by the FDA in 2019 under the brand name Vyleesi for hypoactive sexual desire disorder. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb style=\"font-family: -apple-system, BlinkMacSystemFont, 'San Francisco', 'Segoe UI', Roboto, 'Helvetica Neue', sans-serif; font-size: 0.875rem;\"\u003e\u003cb id=\"docs-internal-guid-e2dec523-7fff-5414-fda0-2b33b6fd40bc\"\u003e\u003c\/b\u003eProduct Details\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₅₀H₆₈N₁₄O₁₀ \/ 1025.2 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 189691-06-3\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes PT-141 a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003ePT-141 traces its origin to the University of Arizona melanocortin research program led by Victor Hruby and Mac Hadley, where structure-activity work on Melanotan 2 produced the now well-known observation that broad-spectrum melanocortin agonism engaged not only pigmentation pathways but also CNS-mediated sexual response circuitry. Palatin Technologies subsequently developed PT-141 (bremelanotide) as a more receptor-selective compound that preserved the CNS activity while attenuating peripheral melanocortin engagement.\u003c\/p\u003e\n\u003cp\u003eWhat distinguishes PT-141 in current research is its regulatory status. In June 2019, the FDA approved bremelanotide under the brand name Vyleesi for hypoactive sexual desire disorder in premenopausal women, making it the only peptide-based melanocortin agonist with full FDA clinical validation in this domain. That approval gives researchers a published Phase 3 dataset, characterized human pharmacokinetics, and a defined mechanism — properties most research peptides lack. Its action is mediated centrally via hypothalamic melanocortin receptors, distinguishing it mechanistically from peripheral vasodilator approaches to sexual dysfunction research.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eCNS-Mediated Sexual Response —\u003c\/b\u003e Animal and clinical studies have characterized PT-141's activation of hypothalamic MC3R and MC4R as the basis for downstream effects on sexual desire and arousal circuitry, distinguishing it from peripheral vasodilator compounds in mechanistic research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eMelanocortin Receptor Pharmacology —\u003c\/b\u003e PT-141 serves as a reference MC3R\/MC4R-preferring agonist in receptor-deconvolution studies, frequently compared against non-selective tools like Melanotan 2 to dissect receptor-subtype contributions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAppetite \u0026amp; Energy Balance —\u003c\/b\u003e Hypothalamic MC4R activation has been studied in animal models for its role in feeding suppression, and PT-141 contributes to the published dataset on MC4R-mediated satiety signaling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePharmacokinetic Characterization —\u003c\/b\u003e As one of few melanocortin peptides with detailed published clinical pharmacokinetic data, PT-141 functions as a reference compound for groups studying cyclic-heptapeptide ADME profiles.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eComparator in Sexual Function Research —\u003c\/b\u003e PT-141's centrally mediated mechanism makes it a frequently used comparator in research designs evaluating peptide-based versus small-molecule approaches to sexual response pathway investigation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with PT-141 often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-melanotan-2-canada\" title=\"View Melanotin II Product Page\"\u003eMelanotan II (MT-2)\u003c\/a\u003e\u003c\/b\u003e — The non-selective parent compound from which PT-141 is derived; the standard mechanistic contrast for receptor-selectivity studies and one of the most common research pairings in the published melanocortin literature.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-tesamorelin-canada\" title=\"View Tesamorelin Product Page\"\u003eTesamorelin\u003c\/a\u003e\u003c\/b\u003e — GHRH analog acting on hypothalamic-pituitary signaling; provides a complementary mechanism for groups studying peptide-mediated CNS-endocrine pathway activity alongside melanocortin research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/ghk-cu\" title=\"View GHK-Cu Product Page\"\u003eGHK-Cu\u003c\/a\u003e\u003c\/b\u003e — Copper tripeptide investigated for skin and ECM remodeling; pairs with PT-141 in research designs spanning the skin-and-sexual-health endpoints common in melanocortin-system studies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhy is PT-141 frequently described as a best peptide for male potential increase research?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePT-141 is the most clinically validated research peptide acting on CNS-mediated sexual response pathways. It engages MC3R and MC4R in hypothalamic circuits associated with sexual desire and arousal, mechanistically distinct from peripheral vasodilator compounds like PDE5 inhibitors. The compound completed Phase 3 clinical trials under the brand name Vyleesi and received FDA approval in 2019 for hypoactive sexual desire disorder. That published dataset, combined with a defined receptor-selectivity profile, places it among the most studied research peptides in male and female sexual response models.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is PT-141 different from Melanotan 2?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBoth are cyclic heptapeptide α-MSH analogs with the same seven-amino-acid sequence. The single structural difference is at the C-terminus: PT-141 ends in a carboxylic acid (-OH), while Melanotan 2 ends in an amide (-NH₂). PT-141 is the active metabolite of Melanotan 2 in vivo. Functionally, the substitution shifts receptor selectivity toward MC3R and MC4R while reducing MC1R engagement, meaning PT-141 retains the CNS-mediated sexual response profile while showing diminished pigmentation activity compared to its parent.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs PT-141 naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. PT-141 is fully synthetic, engineered as a stable cyclic analog of α-MSH, the natural 13-amino-acid melanocortin hormone. The structural modifications — D-phenylalanine substitution, norleucine for methionine, and the Asp-Lys lactam bridge — are non-natural and confer the metabolic stability that endogenous α-MSH lacks.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for PT-141?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePT-141 has one of the most developed evidence bases of any research-relevant melanocortin peptide. Phase 3 clinical trials in premenopausal women with hypoactive sexual desire disorder supported its 2019 FDA approval under the brand name Vyleesi. The preclinical literature spans more than two decades and includes published work in male and female sexual response, melanocortin receptor pharmacology, and pharmacokinetic characterization. Earlier-stage clinical work in male erectile dysfunction was also conducted, providing additional published data points.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":46052264247433,"sku":null,"price":44.99,"currency_code":"CAD","in_stock":false},{"title":"6 x 10mg","offer_id":46052264280201,"sku":null,"price":239.99,"currency_code":"CAD","in_stock":false},{"title":"10 x 10mg (one box)","offer_id":46134036332681,"sku":null,"price":399.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/pt-141-10mg-peptides-canada_standardized.png?v=1778371603"},{"product_id":"ghk-cu","title":"GHK-Cu","description":"\u003ch2\u003e\u003cb\u003eGHK-Cu — Copper Tripeptide for Skin and ECM\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy GHK-Cu in Canada as a research-grade copper tripeptide complex for ECM remodeling, skin biology, hair follicle, and gene expression research designs. GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine, originally isolated by Loren Pickart from human plasma in 1973. The compound is one of the most extensively characterized small peptides in published research, with documented effects on collagen synthesis, glycosaminoglycan production, and approximately 4,000 human gene expression changes. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide complex\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 50 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₁₄H₂₃CuN₆O₄ \/ ~401.91 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 49557-75-7\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes GHK-Cu a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eGHK-Cu was isolated in 1973 by Dr. Loren Pickart from human plasma, after he observed that serum from older donors aged liver tissue cultures more rapidly than serum from younger donors. The factor responsible turned out to be a small copper-binding tripeptide whose endogenous concentration declines with age — from roughly 200 ng\/mL at age 20 to 80 ng\/mL at age 60. The 50-year research arc that followed makes GHK-Cu one of the most thoroughly characterized small peptides in the literature.\u003c\/p\u003e\n\u003cp\u003eWhat distinguishes GHK-Cu among research peptides is its breadth of biological activity relative to its size. Genomic profiling published by Pickart and colleagues identified expression changes across roughly 4,000 human genes, spanning extracellular matrix biology, antioxidant defense, DNA repair, and tumor suppressor pathways. The compound is endogenously released at sites of tissue injury through breakdown of SPARC and type I collagen — meaning its biology connects directly to repair signaling rather than acting as an exogenous-only tool compound.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eSkin \u0026amp; ECM Remodeling —\u003c\/b\u003e Published cell and animal studies have measured GHK-Cu-driven increases in collagen, decorin, and glycosaminoglycan synthesis in dermal fibroblasts, supporting its use as a reference tool in skin biology and ECM research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eWound Repair \u0026amp; Angiogenesis —\u003c\/b\u003e Rodent wound models have reported accelerated re-epithelialization and increased capillary density in GHK-Cu-treated cohorts, with mechanistic work pointing to fibroblast recruitment, immune cell signaling, and pro-angiogenic gene expression.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eHair Follicle Research —\u003c\/b\u003e Animal and ex vivo follicle studies have documented enlargement of hair follicles and extended anagen-phase signaling in GHK-Cu-exposed tissue, generating sustained interest in the peptide for hair biology research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eBroad Gene Expression Modulation —\u003c\/b\u003e Genomic studies have characterized GHK-Cu's effect on the expression of thousands of human genes, including upregulation of DNA repair and tumor suppressor pathways and downregulation of inflammatory mediators — making it a unique tool for transcriptomic research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAntioxidant \u0026amp; Anti-Inflammatory Signaling —\u003c\/b\u003e GHK-Cu modulates copper-dependent enzymatic activity and reduces lipid peroxidation in cell models, with published work linking effects to redox-balance and cytokine-pathway research.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with GHK-Cu often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Pentadecapeptide studied for cytoprotection and tissue repair via nitric oxide and VEGFR2-driven angiogenesis; the most common research pairing with GHK-Cu in soft-tissue and dermal repair designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"file:\/\/\/products\/tb500-peptides\" title=\"View TB-500 Product Page\"\u003eTB-500\u003c\/a\u003e\u003c\/b\u003e — Synthetic thymosin β-4 studied for cellular migration and angiogenesis; complements GHK-Cu's ECM-remodeling profile with a cytoskeletal-mechanism research angle.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/glow-peptide-canada\" title=\"View Glow Stack Product Page\"\u003eGlow Stack\u003c\/a\u003e\u003c\/b\u003e — Combined BPC-157 + TB-500 + GHK-Cu research blend for groups studying skin biology and connective tissue repair across multiple parallel mechanisms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhat should purchasers consider before they buy peptides like GHK-Cu?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThree things matter most: verified purity, identity confirmation, and supply-chain integrity. Our GHK-Cu ships with a batch-specific certificate of analysis confirming ≥99% HPLC purity and mass-spec-verified identity, vials are filled to approximately 104% of label as a quality margin, and orders dispatch from within Canada to avoid border-related cold-chain interruptions. For copper-peptide complexes specifically, batch-level documentation of stoichiometry and copper content is worth confirming before purchase.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the difference between GHK and GHK-Cu?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eGHK is the bare tripeptide (glycyl-L-histidyl-L-lysine), while GHK-Cu is the same tripeptide bound to a copper(II) ion. The tripeptide has high affinity for copper, and most of GHK's documented biological activity in the published literature is mediated by the copper complex — particularly its effects on antioxidant enzyme activity, ECM remodeling, and gene expression. GHK without copper has different and generally weaker activity in most research models.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs GHK-Cu naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eYes. GHK-Cu is endogenously present in human plasma, saliva, and urine, with the tripeptide sequence sitting within larger ECM proteins like SPARC and type I collagen. It is released into circulation when those parent proteins break down at sites of tissue injury. The synthetic peptide sold for research is sequence-identical to the endogenous form.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for GHK-Cu?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe published literature spans more than 50 years and includes biochemical, cell-based, animal, and human studies across wound healing, skin biology, hair follicle research, gene expression profiling, and oncology models. Loren Pickart and colleagues published over 100 papers on GHK biology, including the genomic work that characterized its effect on roughly 4,000 human genes.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"50mg","offer_id":46052984455305,"sku":null,"price":49.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 50mg","offer_id":46134145384585,"sku":null,"price":269.99,"currency_code":"CAD","in_stock":true},{"title":"10 x 50mg(one box)","offer_id":46052984488073,"sku":null,"price":369.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/ghk-cu-50mg-peptide-canada_264aafe9-a507-4b1b-9f40-fbc182a4f91d.png?v=1778370368"},{"product_id":"bpc-157-tb-500-stack","title":"Wolverine Stack (BPC-157 + TB-500)","description":"\u003ch2\u003e\u003cb\u003eBPC-157 + TB-500 Stack — The Wolverine Stack Blend\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe Wolverine Stack combines BPC-157 and TB-500 into a single matched-batch research kit for parallel-pathway tissue repair and recovery research designs. This BPC-157 TB-500 stack is built around mechanistic complementarity — BPC-157 engages nitric oxide signaling and VEGFR2-mediated angiogenesis, while TB-500 engages actin cytoskeleton regulation through G-actin sequestration. The two pathways don't overlap, which means research designs can probe both vascular and cytoskeletal mechanisms simultaneously without confounding mechanism-specific effects. Both compounds in the stack ship at ≥99% HPLC purity with mass-spec-verified identity, separate batch-specific certificates of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Two lyophilized peptides, supplied as a kit\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per kit:\u003c\/b\u003e 10 mg BPC-157 + 10 mg TB-500 (each filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified, both components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified per COA (both components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eComponents:\u003c\/b\u003e See individual product pages for full sequence, formula, MW, and CAS data\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes the Wolverine Stack a Unique Combination\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eThe BPC-157 TB-500 stack reflects what is now the most common pairing in published soft-tissue repair research with these two peptides. The rationale is mechanistic non-overlap: rather than two compounds acting through the same pathway with redundant effects, BPC-157 and TB-500 engage distinct targets — the former operating through nitric-oxide-pathway and VEGFR2 modulation, the latter through actin-cytoskeleton regulation. Research designs that incorporate both compounds can therefore probe parallel repair pathways in the same model system without confounding mechanism-specific effects.\u003c\/p\u003e\n\u003cp\u003eThe combination also reflects the breadth of the underlying literature. BPC-157 has been characterized in over 100 published animal studies spanning gastrointestinal, musculoskeletal, vascular, and neural injury models. The thymosin β-4 literature spans more than four decades and covers wound healing, cardiac repair, neural regeneration, and inflammation. The Wolverine Stack gives Canadian research groups a single supply point for both reference compounds, with batch-specific certificates of analysis confirming ≥99% HPLC purity for each constituent.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eParallel Repair Pathway Investigation —\u003c\/b\u003e The combination allows research designs to address nitric-oxide-pathway and actin-cytoskeleton mechanisms simultaneously, with each peptide serving as a tool for its respective pathway in the same model system.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSoft Tissue \u0026amp; Tendon Models —\u003c\/b\u003e Published rodent studies of Achilles tendon transection, medial collateral ligament injury, and muscle crush have characterized BPC-157 and TB-500 effects independently; combined research designs build on both literatures.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAngiogenesis \u0026amp; Vascular Remodeling —\u003c\/b\u003e Both peptides have documented pro-angiogenic activity — BPC-157 via VEGFR2 upregulation, TB-500 via endothelial cell migration and capillary network organization — making the stack a focused tool for vascular research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCardiac Repair Research —\u003c\/b\u003e Murine ischemia-reperfusion models have separately reported reduced infarct size with TB-500 and improved vascular outcomes with BPC-157, with combined-administration designs appearing in more recent published preclinical work.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eInflammatory Modulation —\u003c\/b\u003e Both compounds have measured effects on cytokine expression and NF-κB signaling in published models, supporting research designs that address tissue repair coupled with inflammatory-pathway endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with the Wolverine Stack often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring BPC-157 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/tb500-peptides\" title=\"View TB-500 Product Page\"\u003eTB-500\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring TB-500 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/glow-peptide-canada\" title=\"View Glow Stack Product Page\"\u003eGlow Stack\u003c\/a\u003e\u003c\/b\u003e — Adds GHK-Cu to the BPC-157 + TB-500 backbone for research designs extending repair endpoints into ECM remodeling and skin biology.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy the BPC-157 TB-500 stack in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur Wolverine Stack ships to Canadian research labs and independent investigators with two batch-specific certificates of analysis — one per component — confirming ≥99% HPLC purity and mass-spec identity verification for both BPC-157 and TB-500. Each vial is filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution work, and orders dispatch from within Canada to avoid border-related cold-chain interruptions.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is the Wolverine Stack different from buying BPC-157 and TB-500 separately?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eFunctionally, the contents are identical to single-compound vials of each peptide. The Wolverine Stack format is a packaging convenience for research designs that always use the two compounds together — kit shipping reduces logistics overhead, and matched batch documentation is provided. For research designs that require one compound at a different ratio than the other, or that don't always use both, sourcing each compound individually may be more appropriate.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhy are BPC-157 and TB-500 so commonly studied together?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe two peptides act through entirely different molecular mechanisms, which makes their combination useful for parallel pathway investigation rather than redundant pathway coverage. BPC-157 modulates nitric oxide signaling and upregulates VEGFR2-mediated angiogenesis. TB-500 regulates the actin cytoskeleton through G-actin sequestration. In published animal studies of soft-tissue injury, the two compounds appear together more frequently than any other peptide pairing in the repair-research literature.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eAre both peptides naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePartially, in different ways. BPC-157's 15-amino-acid sequence corresponds to a region of body protective compound, a protein identified in human gastric juice; the synthetic peptide is the isolated fragment. TB-500 is the synthetic full-length sequence of thymosin β-4, an actin-binding peptide endogenous to most mammalian cell types and originally isolated from calf thymic tissue.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️\u003cem\u003e For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg\/10mg","offer_id":46054364414089,"sku":null,"price":154.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg\/10mg","offer_id":46134481715337,"sku":null,"price":879.99,"currency_code":"CAD","in_stock":false},{"title":"10 x 10mg\/10mg (one box)","offer_id":46054364446857,"sku":null,"price":1149.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/bpc-157-tb-500-wolverine-stack-peptide-canada_standardized_45005065-9a0a-4d37-aaf6-d266514f1b1d.png?v=1778371509"},{"product_id":"glow-peptide-canada","title":"Glow Stack (BPC-157 + TB-500 + GHK-Cu)","description":"\u003ch2\u003e\n\u003cmeta charset=\"utf-8\"\u003eBPC-157 + TB-500 + GHK-Cu Stack — The Glow Stack for Multi-Pathway Research\u003c\/h2\u003e\n\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003eThe Glow Stack combines BPC-157, TB-500, and GHK-Cu into a single matched-batch research kit for multi-pathway dermal repair, ECM remodeling, and tissue-level research designs. Each compound in the BPC-157 TB-500 GHK-Cu stack engages a distinct mechanism — BPC-157 through nitric oxide pathway and VEGFR2-mediated angiogenesis, TB-500 through G-actin sequestration and cellular migration regulation, and GHK-Cu through copper-mediated ECM remodeling and gene expression modulation. The mechanism non-overlap gives research designs three complementary tools in matched documentation. Each component ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificates of analysis, and fast domestic Canadian shipping.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Three lyophilized compounds, supplied as a kit\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per kit:\u003c\/b\u003e 10 mg BPC-157 + 10 mg TB-500 + 50 mg GHK-Cu (each filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified, all components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified per COA (all components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eComponents:\u003c\/b\u003e See individual product pages for full sequence, formula, MW, and CAS data\u003cb\u003e\u003c\/b\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes the Glow Stack a Unique Combination\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eThe Glow Stack builds on the BPC-157 + TB-500 repair backbone — already the most frequent two-peptide pairing in published soft-tissue research — and adds GHK-Cu to extend the design into ECM remodeling, gene-expression modulation, and skin biology. The rationale is mechanistic stratification: each compound operates through a distinct molecular pathway, so research designs incorporating the full stack can probe parallel mechanisms in the same model system without confounding overlap.\u003c\/p\u003e\n\u003cp\u003eThe combination also reflects the breadth of supporting literature. BPC-157 has over 100 published animal studies across repair domains. The thymosin β-4 literature spans four decades. GHK-Cu's published research arc reaches back to its 1973 isolation from human plasma by Loren Pickart, with subsequent genomic profiling identifying expression changes across roughly 4,000 human genes. The Glow Stack gives Canadian research groups a single supply point for all three reference compounds, with batch-specific certificates of analysis confirming ≥99% HPLC purity for each constituent.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eMulti-Pathway Skin \u0026amp; ECM Research —\u003c\/b\u003e The stack allows research designs to address nitric-oxide-pathway, actin-cytoskeleton, and copper-mediated ECM-remodeling mechanisms simultaneously, giving each compound a defined role in the same model system.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCollagen \u0026amp; Glycosaminoglycan Synthesis —\u003c\/b\u003e GHK-Cu has documented effects on dermal fibroblast collagen, decorin, and glycosaminoglycan production. Combined with BPC-157 and TB-500's separate repair-pathway activity, the stack covers structural ECM endpoints alongside vascular and cytoskeletal mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eHair Follicle Research —\u003c\/b\u003e GHK-Cu has measured effects on hair follicle morphology and anagen-phase signaling in animal and ex vivo models. Stacked with BPC-157 and TB-500's vascular and cytoskeletal contributions, the combination supports hair-biology research with multiple parallel mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eWound Repair \u0026amp; Re-Epithelialization —\u003c\/b\u003e All three compounds have published activity in rodent wound models — BPC-157 via cytoprotection and angiogenesis, TB-500 via keratinocyte and fibroblast migration, GHK-Cu via fibroblast recruitment and pro-angiogenic gene expression. Combined research designs build on three independent literatures.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eGene Expression \u0026amp; Transcriptomic Research —\u003c\/b\u003e GHK-Cu's documented activity across thousands of human genes makes the Glow Stack uniquely suited to research designs combining functional repair endpoints with transcriptomic analysis.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with the Glow Stack often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-bpc-157\" title=\"View BPC-157 Product Page\"\u003eBPC-157\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring BPC-157 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/tb500-peptides\" title=\"View TB-500 Product Page\"\u003eTB-500\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring TB-500 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/ghk-cu\" title=\"View GHK-Cu Product Page\"\u003eGHK-Cu\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring GHK-Cu alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/bpc-157-tb-500-stack\" title=\"View Wolverine Stack Product Page\"\u003eWolverine Stack\u003c\/a\u003e\u003c\/b\u003e — The two-compound BPC-157 + TB-500 backbone, for research designs that don't extend into ECM-remodeling and skin-biology endpoints.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhat makes this kit a glow peptide Canada researchers source for skin and ECM work?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThree reasons. First, the published preclinical literature for the constituent compounds — BPC-157, TB-500, and GHK-Cu — covers skin biology, ECM remodeling, hair follicle research, and wound repair across decades of work. Second, the mechanistic stratification across nitric-oxide, cytoskeletal, and copper-mediated ECM pathways gives research designs clean tool separation. Third, sourcing all three compounds as a matched-batch kit shipped from within Canada simplifies documentation and avoids cold-chain interruptions at the border.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is the Glow Stack different from the Wolverine Stack?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe Wolverine Stack is the two-compound BPC-157 + TB-500 repair backbone, focused on soft-tissue and angiogenesis research. The Glow Stack adds GHK-Cu to that backbone, extending the design into ECM remodeling, broad gene-expression modulation, and skin-biology research. Research groups studying tendon, ligament, or muscle repair without dermal endpoints typically work with the Wolverine Stack; groups whose designs include skin, hair, or ECM-remodeling research add GHK-Cu and use the Glow Stack.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhy are these three compounds frequently studied together in skin research?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eEach operates through a distinct mechanism with documented activity in dermal and connective-tissue models. BPC-157 contributes cytoprotection and VEGFR2-mediated angiogenesis. TB-500 contributes cellular migration and capillary network formation through G-actin sequestration. GHK-Cu contributes ECM-remodeling, collagen and glycosaminoglycan synthesis, and broad gene-expression modulation through copper-mediated signaling. Combined research designs cover three parallel mechanisms in a single model.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eAre the three compounds naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eIn varying degrees. BPC-157's 15-amino-acid sequence corresponds to a region of body protective compound found in human gastric juice; the synthetic peptide is the isolated fragment. TB-500 is the synthetic full-length sequence of thymosin β-4, endogenous to most mammalian cell types. GHK-Cu is fully endogenous, present in human plasma, saliva, and urine, and released at sites of tissue injury through breakdown of SPARC and type I collagen. The synthetic preparations are sequence-identical to their endogenous forms.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg\/10mg\/50mg (one vial)","offer_id":46210700640393,"sku":null,"price":164.99,"currency_code":"CAD","in_stock":false},{"title":"6 x 10mg\/10mg\/50mg","offer_id":46210700673161,"sku":null,"price":889.99,"currency_code":"CAD","in_stock":false},{"title":"10 x 10mg\/10mg\/50mg (one box)","offer_id":46210700705929,"sku":null,"price":1299.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/bpc-157-tb-500-ghk-cu-glow-stack-peptide-canada_standardized_2f465125-607f-4157-baaf-dafbcb43a096.png?v=1778371780"},{"product_id":"mots-c-ss31-nad-stack","title":"Mito Stack (MOTS-c + SS-31 + NAD+)","description":"\u003ch2\u003e\u003cb\u003eMOTS-c + SS-31 + NAD+ Stack — The Mito Stack Blend\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe Mito Stack combines MOTS-c, SS-31, and NAD+ into a single matched-batch research kit for three-layer mitochondrial bioenergetics research designs. This MOTS-c SS-31 NAD+ stack addresses mitochondrial biology at three distinct levels — MOTS-c provides signaling-layer intervention through AMPK activation, SS-31 provides structural-layer intervention through cardiolipin binding and cristae stabilization, and NAD+ provides biochemical-layer intervention as the cofactor underlying sirtuin signaling and electron transport chain operation. All three compounds in the stack ship at ≥99% HPLC purity with mass-spec-verified identity, separate batch-specific certificates of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Three lyophilized compounds, supplied as a kit\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per kit:\u003c\/b\u003e 10 mg MOTS-c + 10 mg SS-31 + 600 mg NAD+ (each filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified, all components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified per COA (all components)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light; long-term NAD+ storage at −20 °C\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eComponents:\u003c\/b\u003e See individual product pages for full sequence, formula, MW, and CAS data\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes the Mito Stack a Unique Combination\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eThe MOTS-c SS-31 NAD+ stack reflects a deliberate stratification across the three principal layers of mitochondrial biology that researchers commonly investigate. MOTS-c addresses the signaling layer — communicating bioenergetic status from mitochondria to the nucleus and activating AMPK as a master energy-sensing kinase. SS-31 addresses the structural layer — binding cardiolipin on the inner mitochondrial membrane and stabilizing cristae morphology in compromised mitochondria. NAD+ addresses the biochemical layer — cycling between oxidized and reduced forms in redox reactions and serving as a consumed substrate for sirtuins, PARPs, and CD38.\u003c\/p\u003e\n\u003cp\u003eThis three-layer separation gives research groups clean mechanistic resolution. Rather than three compounds with overlapping modes of action, each operates at a distinct level of mitochondrial biology, allowing experimental designs to probe signaling, structural, and cofactor contributions in the same model system. The combination matches the modern mitochondrial-research literature, where studies frequently address all three layers simultaneously to characterize bioenergetic phenotypes in aging, metabolic, and cardiac models. As a longevity peptide stack Canada-shipped from a single supply point with matched batch documentation, the Mito Stack simplifies the documentation chain for laboratories operating under quality-control protocols.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eThree-Layer Mitochondrial Investigation —\u003c\/b\u003e The combination allows research designs to address signaling (MOTS-c \/ AMPK), structural (SS-31 \/ cardiolipin), and biochemical (NAD+ \/ redox and sirtuin) mechanisms simultaneously, with each compound serving a distinct role in the same model system.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAging \u0026amp; Longevity Research —\u003c\/b\u003e All three compounds connect to age-associated mitochondrial decline. MOTS-c plasma levels decline with age in published human and animal data. SS-31 has been studied in aged-rodent skeletal muscle and cardiac models. NAD+ tissue levels decline progressively with age. Combined research designs build on three independent literatures within longevity research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCardiac Bioenergetics —\u003c\/b\u003e Rodent ischemia-reperfusion models have separately characterized SS-31's effects on infarct size and mitochondrial respiration. NAD+ has been examined in heart failure and cardiometabolic models. MOTS-c has been studied for metabolic effects relevant to cardiac substrate handling. The stack supports research designs combining all three.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eInsulin Sensitivity \u0026amp; Metabolic Models —\u003c\/b\u003e MOTS-c activates AMPK to improve skeletal muscle glucose uptake. SS-31 has been characterized in type 2 diabetes models for effects on oxidative stress and ER stress. NAD+ has documented effects in rodent obesity and NAFLD models. The combination addresses metabolic dysfunction from three angles.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eReactive Oxygen Species \u0026amp; Redox Biology —\u003c\/b\u003e SS-31 reduces mitochondrial ROS production via cardiolipin binding. NAD+ governs cellular redox state through NAD+\/NADH cycling. MOTS-c has been characterized for effects on antioxidant pathways through AMPK-mediated transcription. Combined research designs cover redox biology across structural and biochemical layers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with the Mito Stack often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-mots-c-canada\" title=\"View MOTS-c Product Page\"\u003eMOTS-c\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring MOTS-c alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-ss-31\" title=\"View SS-31 Product Page\"\u003eSS-31\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring SS-31 alone or at non-stack ratios.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/nad-plus\" title=\"View NAD+ Product Page\"\u003eNAD+\u003c\/a\u003e\u003c\/b\u003e — Available as a single-compound vial for research designs requiring NAD+ alone or at non-stack ratios.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy the MOTS-c SS-31 NAD+ stack in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur Mito Stack ships to Canadian research labs and independent investigators with three batch-specific certificates of analysis — one per component — confirming ≥99% HPLC purity and mass-spec identity verification for MOTS-c, SS-31, and NAD+. Each vial is filled to approximately 104% of label as a quality margin for residual losses during reconstitution work, and orders dispatch from within Canada to avoid border-related cold-chain interruptions.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow are MOTS-c, SS-31, and NAD+ different from each other mechanistically?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eMOTS-c is a 16-amino-acid mitochondria-derived peptide that activates AMPK and acts as a signaling molecule between mitochondria and the nucleus — a regulatory mechanism. SS-31 is a synthetic tetrapeptide that binds cardiolipin on the inner mitochondrial membrane to stabilize cristae structure and reduce ROS production — a structural mechanism. NAD+ is a pyridine dinucleotide coenzyme that participates in redox cycling and serves as a consumed substrate for sirtuins, PARPs, and CD38 — a biochemical mechanism. The three compounds operate at different levels of mitochondrial biology.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhy combine these three compounds in a single research kit?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe combination matches how mitochondrial-research designs are typically structured. Studies of mitochondrial dysfunction in aging, cardiac disease, metabolic syndrome, and neurodegeneration often address signaling, structural, and biochemical layers simultaneously — because dysfunction at one layer typically propagates to the others. A single kit gives research groups all three reference compounds with matched batch documentation, simplifying experimental designs that probe parallel mechanisms.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs NAD+ a peptide?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. NAD+ is a pyridine dinucleotide coenzyme — two nucleotides linked through their phosphate groups, not assembled from amino acids. It is included in the Mito Stack and catalogued alongside research peptides because of its central role in mitochondrial bioenergetics and its frequent appearance in research designs alongside MOTS-c and SS-31. Many suppliers serving the mitochondrial research domain carry both peptide and non-peptide compounds in this category.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg\/10mg\/600mg (one vial)","offer_id":46211113713801,"sku":null,"price":164.99,"currency_code":"CAD","in_stock":false},{"title":"6 x 10mg\/10mg\/600mg","offer_id":46211113746569,"sku":null,"price":899.99,"currency_code":"CAD","in_stock":false},{"title":"10 x 10mg\/10mg\/600mg (one box)","offer_id":46211113779337,"sku":null,"price":1369.99,"currency_code":"CAD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/mots-c-ss-31-nad_-mito-stack-peptide-canada_standardized_7a60a455-0cdf-4180-aa0a-b728c3f5e20c.png?v=1778371936"},{"product_id":"nad-plus","title":"NAD+","description":"\u003ch2\u003e\u003cb\u003eNAD+ – \u003cmeta charset=\"utf-8\"\u003eβ-Nicotinamide Adenine Dinucleotide\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy NAD+ in Canada as a research-grade β-nicotinamide adenine dinucleotide for cellular bioenergetics, sirtuin biology, DNA damage response, and mitochondrial research designs. NAD+ is a pyridine dinucleotide coenzyme that operates as both an electron acceptor in cellular respiration and a substrate for sirtuin deacetylases, PARP enzymes, and CD38. Tissue NAD+ levels decline progressively with age, making the compound central to aging research and the broader field of cellular bioenergetics. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized free acid\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 600 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light; long-term storage at −20 °C\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₂₁H₂₇N₇O₁₄P₂ \/ 663.43 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 53-84-9\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes NAD+ a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eNAD+ was first identified in 1906 by Arthur Harden and William Young as a low-molecular-weight cofactor in boiled yeast extracts, and was subsequently linked to pellagra prevention through niacin metabolism by Conrad Elvehjem in 1937. The molecule's structural simplicity — two nucleotides linked through their phosphate groups — masks an extraordinary biological reach: NAD+ participates in hundreds of enzymatic reactions across all known living cells.\u003c\/p\u003e\n\u003cp\u003eWhat distinguishes NAD+ in current research is its dual identity as both a redox cofactor and a consumed substrate. The redox cycling between NAD+ and NADH supports oxidative phosphorylation and ATP synthesis. Separately, NAD+ is consumed by sirtuin deacetylases, PARP enzymes during DNA damage response, and CD38 during cyclic ADP-ribose signaling. This consumption-versus-recycling distinction is central to the modern NAD+ literature — researchers studying age-related NAD+ decline focus on the balance between salvage-pathway synthesis and consuming-enzyme demand. Research groups examining mitochondrial dysfunction, metabolic syndrome, and aging frequently use NAD+ as a tool compound to probe sirtuin-pathway biology and bioenergetic regulation.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eMitochondrial Bioenergetics —\u003c\/b\u003e NAD+ serves as the primary electron acceptor in glycolysis, the TCA cycle, and fatty acid oxidation, making it a foundational tool compound in studies of cellular energy metabolism and mitochondrial function across in vitro and in vivo models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSirtuin Pathway Activation —\u003c\/b\u003e Sirtuins (SIRT1–SIRT7) consume NAD+ to deacetylate histone and non-histone protein substrates, and NAD+ availability is the rate-limiting input for sirtuin activity. Published research has used NAD+ to probe sirtuin-mediated regulation of metabolic, longevity, and stress-response pathways.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eDNA Damage Response \u0026amp; PARP Activity —\u003c\/b\u003e Poly(ADP-ribose) polymerases consume large quantities of NAD+ during DNA damage response signaling. Research groups studying genotoxic stress, chemotherapy response, and aging-associated DNA damage frequently incorporate NAD+ as a substrate in cell-based and animal designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAging \u0026amp; Longevity —\u003c\/b\u003e Published human and animal data document age-associated declines in tissue NAD+ levels, with replenishment strategies in rodent models linked to improvements in mitochondrial function, insulin sensitivity, and physical performance markers in aged cohorts.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eMetabolic \u0026amp; Cardiometabolic Models —\u003c\/b\u003e NAD+ supplementation in rodent models of obesity, insulin resistance, and NAFLD has been examined for effects on glucose homeostasis, hepatic lipid handling, and inflammatory markers, generating sustained interest in NAD+ as a research tool for cardiometabolic-pathway investigation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with NAD+ often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca title=\"View MOTS-c Product Page\" href=\"https:\/\/emeraldpeptides.ca\/products\/buy-mots-c-canada\"\u003eMOTS-c\u003c\/a\u003e\u003c\/b\u003e — Mitochondria-derived peptide studied for insulin sensitivity and exercise-mimetic activity; frequently co-investigated with NAD+ in mitochondrial health and metabolic research.\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-retatrutide-canada\" title=\"View Retatrutide Product Page\"\u003e\u003cstrong\u003eRetatrutide (GLP-3)\u003c\/strong\u003e\u003c\/a\u003e \u003cmeta charset=\"utf-8\"\u003e— Cardiometabolic research designs increasingly pair NAD+ with incretin-class compounds like Retaturide.\u003cmeta charset=\"utf-8\"\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca title=\"View SS-31 Product Page\" href=\"https:\/\/emeraldpeptides.ca\/products\/buy-ss-31\"\u003eSS-31\u003c\/a\u003e\u003c\/b\u003e — Mitochondria-targeted antioxidant peptide studied for cardioprotection and mitochondrial membrane stabilization; co-formulated with NAD+ and MOTS-c in the Mito Stack.\u003cb\u003e\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca title=\"View Mito Stack Product Page\" href=\"https:\/\/emeraldpeptides.ca\/products\/mots-c-ss31-nad-stack\"\u003eMito Stack\u003c\/a\u003e\u003c\/b\u003e — Combined MOTS-c + SS-31 + NAD+ research blend for groups studying mitochondrial function across signaling, structural, and cofactor mechanisms in parallel.\u003cmeta charset=\"utf-8\"\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhy are we considered among the best places to buy peptides Canada — including NAD+?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eResearchers source from us for three reasons: every batch is HPLC-tested to ≥99% purity with MS-verified identity, every vial ships with a batch-specific certificate of analysis, and orders dispatch from within Canada to avoid border-related cold-chain interruptions. NAD+ vials are filled to approximately 104% of the labeled 600 mg as a quality margin for residual losses during reconstitution.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs NAD+ a peptide?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. NAD+ is a pyridine dinucleotide coenzyme — two nucleotides linked through their phosphate groups, with one bearing a nicotinamide base and the other an adenine base. It is not a peptide and is not assembled from amino acids. It is catalogued alongside research peptides because of its significant overlap with peptide research in mitochondrial, metabolic, and longevity work, and because suppliers serving those research domains typically carry both classes of compound.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow does NAD+ differ from NMN or NR?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNAD+ is the active coenzyme used directly in cellular reactions. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors that cells convert into NAD+ through the salvage pathway. Research designs use the precursors when targeting endogenous synthesis pathways and use NAD+ directly when probing redox biology, sirtuin substrate kinetics, or PARP-pathway research.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for NAD+ research?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe NAD+ literature spans more than a century, beginning with Harden and Young's 1906 yeast extract work. Modern interest accelerated after sirtuin biology was characterized in the 2000s and after Imai, Sinclair, and others linked NAD+ decline to age-related metabolic dysfunction. Published research now spans biochemistry, mitochondrial bioenergetics, longevity, neurodegeneration, cardiometabolic, and DNA damage response domains across cell, animal, and human study designs.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"600mg","offer_id":46211766681737,"sku":null,"price":109.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 600mg","offer_id":46211766714505,"sku":null,"price":599.0,"currency_code":"CAD","in_stock":true},{"title":"10 x 100mg (one box)","offer_id":46211766747273,"sku":null,"price":849.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/nad_-600mg-peptide-canada_standardized.png?v=1778370424"},{"product_id":"buy-ss-31","title":"SS-31","description":"\u003ch2\u003e\u003cb\u003eBuy SS-31 Canada — Mitochondria-Targeted Tetrapeptide\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy SS-31 in Canada as a research-grade mitochondria-targeted tetrapeptide for cardiolipin binding, mitochondrial structural integrity, and bioenergetics research designs. SS-31 (also known as elamipretide) is a synthetic aromatic-cationic tetrapeptide developed in the early 2000s by Hazel Szeto and Peter Schiller at Cornell University and the Clinical Research Institute of Montreal. The compound binds cardiolipin on the inner mitochondrial membrane and stabilizes cristae structure, with downstream effects on electron transport chain efficiency and reactive oxygen species reduction. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₃₂H₄₉N₉O₅ \/ 639.8 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 736992-21-5\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes SS-31 a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eSS-31 was developed in the early 2000s by Hazel Szeto and Peter Schiller as part of a research program at Cornell University and the Clinical Research Institute of Montreal aimed at producing cell-permeable peptide antioxidants. The Szeto-Schiller series introduced an alternating aromatic-cationic motif that allowed the peptides to cross plasma and mitochondrial membranes without requiring active transport — a defining property that distinguishes them from earlier mitochondrial-targeted compounds.\u003c\/p\u003e\n\u003cp\u003eWhat sets SS-31 apart from other mitochondrial research tools is its mechanism of localization. Unlike triphenylphosphonium-based mitochondrial targeting strategies that rely on membrane potential, SS-31 binds cardiolipin directly and concentrates in the inner mitochondrial membrane independent of bioenergetic state. This makes it a reliable tool in research models where mitochondrial membrane potential is compromised — including ischemia-reperfusion, heart failure, and tafazzin-deficient cardiolipin-remodeling systems where conventional mitochondrial probes fail.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eCardiolipin Stabilization \u0026amp; Cristae Structure —\u003c\/b\u003e Published cell and animal studies have measured SS-31-driven preservation of cristae morphology and cardiolipin content in mitochondrial dysfunction models, with mechanistic work pointing to direct cardiolipin binding via the peptide's aromatic-cationic motif.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eReactive Oxygen Species Reduction —\u003c\/b\u003e SS-31 inhibits cardiolipin peroxidation and reduces mitochondrial ROS production in oxidative stress models, supporting its use as a reference tool in research designs probing redox-balance and antioxidant pathway biology.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCardiac Ischemia-Reperfusion —\u003c\/b\u003e Preclinical work in rodent cardiac IR injury has reported reduced infarct size and preserved mitochondrial respiration in SS-31-treated cohorts, making the peptide a frequently cited tool in cardiac bioenergetics research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eSkeletal Muscle Bioenergetics —\u003c\/b\u003e Aged-rodent studies have measured improvements in skeletal muscle ATP production, exercise tolerance, and fatigue resistance following SS-31 exposure, generating sustained interest in the peptide for mitochondrial-myopathy and aging-muscle research.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eRenal \u0026amp; Neural Mitochondrial Research —\u003c\/b\u003e Published animal models of renal ischemia, atherosclerotic renal artery stenosis, and neurodegeneration have characterized SS-31's effects on mitochondrial function in non-cardiac tissue, expanding its utility as a tool compound across multiple research domains.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with SS-31 often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-retatrutide-canada\" title=\"View Retatrutide Product Page\"\u003e\u003cstrong\u003eRetatrutide (GLP-3)\u003c\/strong\u003e\u003c\/a\u003e \u003cmeta charset=\"utf-8\"\u003e — SS-31's documented T2D research overlaps with the glycemic-endpoint literature for Retatrutide.\u003cb\u003e\u003c\/b\u003e\u003cb\u003e\u003c\/b\u003e\u003cb\u003e\u003c\/b\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-mots-c-canada\" title=\"View MOTS-c Product Page\"\u003eMOTS-c\u003c\/a\u003e\u003c\/b\u003e — Mitochondria-derived signaling peptide that activates AMPK; complements SS-31's structural cardiolipin-stabilization mechanism with a signaling-pathway angle, and pairs with both compounds in our Mito Stack (see below). \u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/nad-plus\" title=\"View NAD+ Product Page\"\u003eNAD+\u003c\/a\u003e\u003c\/b\u003e — Mitochondrial cofactor central to sirtuin signaling and redox balance; the third compound in the Mito Stack and a frequent companion in bioenergetics research designs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/mots-c-ss31-nad-stack\" title=\"View Mito Stack Product Page\"\u003eMito Stack\u003c\/a\u003e\u003c\/b\u003e — Combined MOTS-c + SS-31 + NAD+ research blend for groups studying mitochondrial function across signaling, structural, and cofactor mechanisms in parallel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can I buy SS-31 in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur SS-31 ships to Canadian research labs and independent investigators with a batch-specific certificate of analysis confirming ≥99% HPLC purity and mass-spec identity verification. Vials are filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution work, and ship from within Canada to avoid border-related cold-chain interruptions.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is SS-31 different from MOTS-c?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eBoth are mitochondria-focused peptides but engage entirely different mechanisms. SS-31 is a synthetic tetrapeptide that binds cardiolipin on the inner mitochondrial membrane to stabilize cristae structure and reduce ROS production — a structural mechanism. MOTS-c is a 16-amino-acid mitochondria-derived peptide that activates AMPK and acts as a mitochondrial-nuclear retrograde signal — a signaling mechanism. Many research designs use them together to address mitochondrial function from both structural and signaling angles.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs SS-31 naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eNo. SS-31 is fully synthetic, designed by Szeto and Schiller as part of a structure-activity program targeting mitochondrial peptide antioxidants. The aromatic-cationic motif and the inclusion of D-arginine and 2',6'-dimethyltyrosine are deliberately non-natural, conferring both protease resistance and the cardiolipin-binding selectivity that defines the compound.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eWhat is the evidence base for SS-31?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe published preclinical literature spans more than two decades and covers cardiac ischemia-reperfusion, heart failure, mitochondrial myopathy, renal ischemia, neurodegeneration, type 2 diabetes, and aging-related muscle dysfunction across cell, rodent, and large-animal models. Clinical trials have been conducted under the development codes elamipretide and MTP-131 in cardiomyopathy, mitochondrial myopathy, and Barth syndrome populations, providing a substantial human pharmacokinetic and safety dataset.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":46211938615433,"sku":null,"price":59.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg","offer_id":46211938648201,"sku":null,"price":329.99,"currency_code":"CAD","in_stock":true},{"title":"10 x 10mg (one box)","offer_id":46211938680969,"sku":null,"price":489.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/ss-31-10mg-peptide-canada_standardized_dba7d997-92cc-4750-a55f-9f8f9fa5f3f2.png?v=1778372064"},{"product_id":"buy-hgh-fragment-176-191-canada","title":"HGH Fragment (176-191)","description":"\u003ch2\u003e\u003cb\u003eBuy HGH Fragment 176-191 Canada — Lipolytic hGH Peptide\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuy HGH Fragment 176-191 in Canada as a research-grade lipolytic peptide fragment for adipose tissue research designs decoupled from the GH\/IGF-1 axis. HGH Fragment 176-191 corresponds to the C-terminal 16 amino acids of human growth hormone — the region that retains lipolytic activity but lacks the residues required for IGF-1 stimulation. Developed in the late 1990s by Frank Ng and colleagues at Monash University, the compound was subsequently advanced through Phase 2 clinical trials in obesity research under the development code AOD-9604. Each vial supplied by Emerald Peptides ships at ≥99% HPLC purity with mass-spec-verified identity, batch-specific certificate of analysis, and fast domestic Canadian shipping.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eProduct Details\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eForm:\u003c\/b\u003e Lyophilized peptide\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eNet per vial:\u003c\/b\u003e 10 mg (filled to approximately 104% of label)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003ePurity:\u003c\/b\u003e ≥99% (HPLC-verified)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eIdentity:\u003c\/b\u003e MS-verified (per COA)\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eStorage:\u003c\/b\u003e 2–8 °C, protect from light\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eFormula \/ M.W.:\u003c\/b\u003e C₇₈H₁₂₅N₂₃O₂₃S₂ \/ 1817.12 Da\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCAS:\u003c\/b\u003e 221231-10-3\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eWhat Makes HGH Fragment 176-191 a Unique Compound\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eHGH Fragment 176-191 was developed in the late 1990s by Frank Ng and colleagues at Monash University, Australia, as part of a structure-activity program designed to isolate the lipolytic domain of human growth hormone from its broader endocrine activity. The compound was subsequently licensed to Metabolic Pharmaceuticals — later Calzada — and advanced through Phase 2 clinical trials in obesity in the early 2000s under the development code AOD-9604.\u003c\/p\u003e\n\u003cp\u003eWhat distinguishes the fragment in research is its mechanistic specificity. Full-length hGH binds the GH receptor and triggers the complete cascade — IGF-1 elevation, growth signaling, glucose handling, and lipolysis. By using only the C-terminal 16 residues, HGH Fragment 176-191 retains lipolytic activity without engaging the GH receptor in the IGF-1-stimulating mode. That decoupling gives Canadian research groups a clean tool for studying adipose-specific hGH actions in isolation from the systemic GH\/IGF-1 axis effects that confound full-hGH study designs.\u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eKey Benefits\u003c\/b\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003eLipolysis \u0026amp; Fatty Acid Mobilization —\u003c\/b\u003e Published preclinical studies have characterized HGH Fragment 176-191's activation of hormone-sensitive lipase and stimulation of fatty acid release from adipose tissue, with effects observed in both subcutaneous and visceral adipocyte models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eAnti-Lipogenic Activity —\u003c\/b\u003e Animal studies have measured reductions in fatty acid synthesis alongside increased lipolysis, generating sustained interest in the fragment as a research tool for adipose-specific dual-mechanism investigation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eBody Composition Models —\u003c\/b\u003e Rodent obesity models have reported reductions in fat mass without proportional changes in lean mass following HGH Fragment 176-191 administration, with mechanistic work attributing the selectivity to the absence of GH-receptor-mediated growth signaling.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eDecoupled Metabolic Research —\u003c\/b\u003e Unlike full hGH, the fragment does not substantially elevate IGF-1 or alter glucose homeostasis in published animal models, making it a useful tool for research designs requiring lipolysis activity without confounding GH\/IGF-1 axis effects.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003eCartilage \u0026amp; Joint Research —\u003c\/b\u003e A subset of preclinical work has examined HGH Fragment 176-191 in osteoarthritis and cartilage degradation models, characterizing effects on chondrocyte signaling that are mechanistically distinct from its primary lipolytic profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eRelated Peptides\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eResearchers working with HGH Fragment 176-191 often investigate it alongside:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-tesamorelin-canada\" title=\"View Tesamorelin Product Page\"\u003eTesamorelin\u003c\/a\u003e\u003c\/b\u003e — GHRH analog that stimulates pituitary GH release and triggers the full GH\/IGF-1 cascade; the standard mechanistic contrast for research designs comparing isolated lipolytic activity against full-axis activation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-retatrutide-canada\" title=\"View Retatrutide Product Page\"\u003eRetatrutide (GLP-3)\u003c\/a\u003e\u003c\/b\u003e — Triple GLP-1\/GIP\/glucagon agonist with documented adiposity-research data; provides a receptor-level metabolic-pathway contrast to HGH Fragment 176-191's adipocyte-direct lipolytic mechanism.\u003c\/li\u003e\n\u003cli\u003e\n\u003cb\u003e\u003ca href=\"https:\/\/emeraldpeptides.ca\/products\/buy-mots-c-canada\" title=\"View MOTS-c Product Page\"\u003eMOTS-c\u003c\/a\u003e\u003c\/b\u003e — Mitochondria-derived peptide that activates AMPK; complements HGH Fragment 176-191's lipolytic profile with a cellular-energetics angle on metabolic research.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cb\u003eFrequently Asked Questions\u003c\/b\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cb\u003eWhere can researchers buy HGH Fragment 176-191 in Canada with verified purity?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eOur HGH Fragment 176-191 ships to Canadian research labs and independent investigators with a batch-specific certificate of analysis confirming ≥99% HPLC purity and mass-spec identity verification. Vials are filled to approximately 104% of the labeled 10 mg as a quality margin for residual losses during reconstitution work, and ship from within Canada to avoid border-related cold-chain interruptions.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eHow is HGH Fragment 176-191 different from Tesamorelin or full hGH?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe three operate at different points in the GH axis. Full hGH binds the GH receptor and triggers the complete cascade — IGF-1 production, growth signaling, glucose modulation, and lipolysis. Tesamorelin is a GHRH analog that stimulates pituitary GH release, indirectly producing the full hGH cascade. HGH Fragment 176-191 isolates only the C-terminal lipolytic region of hGH, retaining fat-mobilization activity without engaging the GH receptor in the IGF-1-stimulating mode. Research designs select among the three based on whether full-axis activation, indirect GH stimulation, or isolated lipolysis is the relevant mechanism.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs HGH Fragment 176-191 the same as AOD-9604?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003eThe two are closely related and frequently treated as synonymous in research peptide markets. HGH Fragment 176-191 refers to the synthetic 16-amino-acid sequence corresponding to residues 176-191 of human growth hormone. AOD-9604 is the same fragment as developed by Metabolic Pharmaceuticals and tested in Phase 2 clinical trials in obesity. Most research suppliers use the names interchangeably, and the published preclinical literature largely treats them as equivalent compounds.\u003c\/p\u003e\n\u003ch3\u003e\u003cb\u003eIs HGH Fragment 176-191 naturally occurring?\u003c\/b\u003e\u003c\/h3\u003e\n\u003cp\u003ePartially. The 16-amino-acid sequence corresponds exactly to residues 176-191 of native human growth hormone, an endogenous peptide hormone produced by the anterior pituitary. The fragment itself does not occur freely in nature — it is a synthetic peptide isolated from the parent hGH sequence to study the lipolytic activity of that specific region. The synthetic peptide sold for research is sequence-identical to the corresponding region of native hGH.\u003c\/p\u003e\n\u003chr\u003e\n\u003cp\u003e⚠️ \u003cem\u003eFor research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.\u003c\/em\u003e\u003c\/p\u003e","brand":"Emerald Peptides","offers":[{"title":"10mg","offer_id":46398509187209,"sku":null,"price":99.99,"currency_code":"CAD","in_stock":true},{"title":"6 x 10mg","offer_id":46398509219977,"sku":null,"price":529.99,"currency_code":"CAD","in_stock":true},{"title":"10 x 10mg (one box)","offer_id":46398509252745,"sku":null,"price":829.99,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0760\/3424\/4745\/files\/HGH-peptides-canada_35c07665-3aad-4426-b8fb-58e6a6ad45ba.png?v=1778370270"}],"url":"https:\/\/emeraldpeptides.ca\/collections\/peptides-canada.oembed","provider":"Emerald Peptides","version":"1.0","type":"link"}